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Abstract
Coronary artery disease (CAD) remains the world’s leading cause of mortality and the disease
burden is continually expanding as the population ages. Recently, the MR-INFORM randomised
trial has demonstrated that the management of patients with stable CAD can be guided by
stress perfusion cardiovascular magnetic resonance (CMR) imaging and it is non-inferior to
the using the invasive reference standard of fractional flow reserve. The benefits of using
stress perfusion CMR include that it is non-invasive and significantly reduces the number of
unnecessary coronary revascularisations. As compared to other ischaemia tests, it boasts a
high spatial resolution and does not expose the patient to ionising radiation. However, the
main limitation of stress perfusion CMR is that the diagnostic accuracy is highly dependent
on the level of training of the operator, resulting in the test only being performed routinely in
experienced tertiary centres.
The clinical translation of stress perfusion CMR would be greatly aided by a fully-
automated, user-independent, quantitative evaluation of myocardial blood flow. This thesis
presents major steps towards this goal: robust motion correction, automated image processing,
reliable quantitative modelling, and thorough validation. The motion correction scheme makes
use of data decomposition techniques, such as robust principal component analysis, to mitigate
the difficulties in image registration caused by the dynamic contrast enhancement. The motion
corrected image series are input to a processing pipeline which leverages the recent advances
in image processing facilitated by deep learning. The pipeline utilises convolutional neural net-
works to perform a series of computer vision tasks including myocardial segmentation and right
ventricular insertion point detection. The tracer-kinetic model parameters are subsequently
estimated using a Bayesian inference framework. This incorporates the prior information
that neighbouring voxels are likely to have similar kinetic parameters and thus improves the
reliability of the estimated parameters. The full process is validated in a well characterised
patient population against coronary angiography and invasive measurements. It is shown to be
accurate at detecting reductions in myocardial blood flow while further discriminating between
patients with no significant CAD and those with obstructed coronary arteries or microvascular
dysfunction.
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Stress perfusion cardiovascular magnetic resonance (CMR) imaging has a class IA indication
in the European guidelines for the evaluation of patients with an intermediate risk of coronary
artery disease [1]. However, myocardial perfusion imaging is performed far less frequently with
CMR than with the alternative nuclear imaging approaches: single-photon emission computed
tomography (SPECT) and positron emission tomography (PET). This is despite the fact that
CMR boasts superior spatial resolution, a lack of ionising radiation, and can also provide a full
assessment of cardiac function and tissue viability. Furthermore, multiple trials and studies
have shown CMR to have at least comparable diagnostic accuracy to SPECT [2, 3] and to be
non-inferior to invasive measurements for the management of patients [4].
In fact, stress perfusion CMR is primarily used in highly experienced centres and there is a
need to encourage its adoption in less specialised centres. This need, however, is hampered by
the dependence of the diagnostic accuracy of the test on the level of training of the operator
[5]. A possible solution to this is the quantification of myocardial perfusion which offers a
user-independent assessment of the images that could facilitate the adoption of stress perfusion
CMR in less specialised centres.
The aim of this thesis is to develop methods to overcome the technical difficulties of
quantitative myocardial perfusion CMR. Challenges such as respiratory motion, the reliability
of the analysis, and the time consuming processing have lead to the approach only being used
as a research tool and not in clinical practice. This thesis deals with the contrast-enhancement
during motion compensation in a principled manner, introduces more robust kinetic parameter
estimation approaches and combines this with a deep learning-based image processing pipeline
to make the analysis fully automated. The initial clinical validation of the proposed methods is
also reported.
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1.2 Contribution of the thesis
The original contributions of the thesis can be summarised as follows:
• Robust motion compensation. The motion compensation of myocardial perfusion
CMR, using image registration, is difficult due to the rapidly changing contrast during
the passing of the gadolinium bolus. This invalidates the assumptions of the similarity
measures optimised in the image registration. This work proposes the use of robust
principal component analysis (RPCA) to decompose the baseline signal from the dynamic
contrast-enhancement. Image registration is then more readily applied in the absence of
the dynamic contrast-enhancement. The proposed approach is evaluated qualitatively by
expert clinicians, as well as quantitatively.
• Fully automated image processing. Deep learning is used to automate the computer
vision tasks required for the quantitative modelling. This includes the automation of
the myocardial segmentation, the identification of the arterial input function, and the
detection of the right ventricular insertion points. Each step is evaluated individually
using a suitable metric and additionally, the full automated pipeline is compared to the
manual processing.
• Reliable quantitative modelling. The identification of the tracer-kinetic parameters
from the imaging data is an ill-posed inverse problem, and as such, the estimated values
are subject to uncertainties [6]. This work introduces Bayesian inference as a principled
approach to incorporate prior information in the parameter estimation. In particular, the
prior knowledge that neighbouring pixels are likely to have similar kinetics is used to
constrain the parameter estimation and improve reliability.
Furthermore, an initial assessment of the performance of the proposed pipeline in compari-
son to invasive coronary angiography. This is performed on an external validation set (i.e, none
of the patient data considered in this assessment has been used in the development of any of the
underlying methods) to give an accurate reflection of the clinical performance.
1.3 Outline of the thesis 3
1.3 Outline of the thesis
The thesis is organised into 7 further chapters, the contents of which are:
• Chapter 2: a brief background on the physiology and pathophysiology of coronary
artery disease is first provided. The chapter subsequently gives an overview of some of
the imaging approaches to diagnosing coronary artery disease.
• Chapter 3: gives an introduction to myocardial perfusion CMR. This includes the
background on the MR acquisition of the data, the tracer-kinetic modelling, and a review
of the state-of-the-art approaches in the literature.
• Chapter 4: introduces the problem of motion compensation of myocardial perfusion
CMR, and describes RPCA and how it is used. The proposed approach to the problem is
then described and evaluated.
• Chapter 5: firstly, introduces the image processing problems and gives the requisite
deep learning background. It then describes the automated image processing pipeline and
considers its application and evaluation. The pipeline is further compared to the manual
processing by expert operators.
• Chapter 6: discusses the limitations of the conventional parameter estimation methods.
Then, the Bayesian approach with spatial priors is developed and evaluated both in
simulated and patient data.
• Chapter 7: applies the methods developed in Chapters 4-6 prospectively to an ini-
tial patient cohort and reports the diagnostic accuracy in comparison to the invasive
measurements.
• Chapter 8: summarises the contributions made in this thesis and considers both the
future work required and the potential clinical impact of that work.
Chapter 2
Background
2.1 Cardiac anatomy and function
The heart is the centre of the cardiovascular system. It acts as a pump in order to distribute
oxygen and nutrients to the tissue around the body and to subsequently remove waste products
[7]. This function is essential for sustaining activity in the tissue and to avoid tissue necrosis.
The heart is responsible for the circulation of both oxygenated and deoxygenated blood and
does so using a series of chambers and vessels, as shown in Figure 2.1. In order to deal with
both the distribution of oxygenated blood and the reception of deoxygenated blood, the heart
is divided into two systems: the pulmonary circulatory system and the systemic circulatory
system. The pulmonary circulation starts at the right atrium from which the right ventricle
is filled with deoxygenated blood. The right ventricle then pumps this blood to the lungs
through the pulmonary arteries. The blood is oxygenated in the lungs and returns to the heart,
specifically the left atrium, through the pulmonary veins. In the systemic circulation, the left
ventricle is filled from the left atrium and the blood is pumped, through the aorta, around the
body. Deoxygenated blood returns to the heart through the superior and inferior venae cavae to
complete the cycle.
The heart muscle, as shown in Figure 2.2, is made up of three layers: a thick middle layer
known as the myocardium, the inner endocardium, and the outer epicardium (also known as the
visceral pericardium). As with all other tissue, cardiac muscle requires oxygen and nutrients in
order to sustain viability and keep pumping blood. The cardiac tissue does not receive oxygen
and nutrients by simply holding oxygenated blood. Thus, the requisite oxygen and nutrients
need to be delivered to the muscle and this is done through the coronary circulatory system.
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Fig. 2.1 The anatomy of the heart with the chambers, major vessels and valves labelled. The
colour blue indicates the structure is a constituent part of the pulmonary circulatory system and
similarly red identifies the systemic circulatory system, taken from [8].
Fig. 2.2 The underlying structure of the cardiac muscle, adapted from [9].
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2.2 The coronary circulatory system
The passage of blood between the chambers of the heart is controlled by four valves, shown
in Figure 2.1, which separate the atria from the ventricles and the ventricles from a blood
vessel. The valves are made of leaflets (flaps) which are opened and closed by changing
flow and pressure. The left ventricle is separated from the aorta by the aortic valve. On the
leaflets of the aortic valve lies the coronary ostium, the openings of the left and right coronary
arteries. The left coronary artery (LCA) branches into the left anterior descending (LAD) and
left circumflex (LCx) branches. The right coronary artery (RCA), the LAD, and LCx further
subdivide in order to cover the breadth of the epicardium and distribute oxygen and nutrients to
the muscle. Though the exact anatomical structure varies from person to person, generally, the
RCA supplies the right atrium, right ventricle, and the back of the septum. The front of the
septum is supplied by the LAD, as well as the front and bottom of the left ventricle. The left
atrium and the back and side of the left ventricle is supplied by the LCx [10].
The coronary circulatory system performs a particularly important role as the myocardium
demands 20 times more oxygen than skeletal muscle, at peak heart rate [7]. To satisfy this high
demand, even under normal resting conditions the myocardium needs to extract 70-80% of
the available oxygen [11]. During exercise, the rate at which the heart beats increases in order
to satisfy the increased systemic demand for oxygen and thus the myocardium also demands
more oxygen. Since the extraction rate of oxygen from blood is already high, there is limited
scope for increased extraction and the increased demand must be met by increasing coronary
blood flow [7].
Fig. 2.3 The coronary arteries shown traversing the wall of the heart, adapted from [12].
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Coronary blood flow is primarily driven by the pressure gradient between the aorta and the
right atrium [10]. Since the coronaries are constricted when the is heart contracted (systole)
most flow occurs when the heart is relaxed (diastole). This further inhibits coronary blood flow
at higher heart rate. As the heart rate increases, the diastolic proportion of the cardiac cycle
falls faster than systole, leading to less unrestricted flow [7]. Blood also flows faster through
wider vessels, as there is less resistance. Natural or pharmacologically-induced vasodilation
thus increase blood flow [10]. Conversely, the narrowing of the vessels can lead to reduced
flow. The coronary arteries can be narrowed by atherosclerosis. This is a disease in which there
is a build-up of plaque in the walls of the vessels.
The heart has an innate ability to adapt to changing circumstances. In a processes known
as autoregulation, blood flow is well regulated in spite of changes in the available pressure
gradient [13]. For example, in the case of the narrowing of a vessel, there will be a proportional
increase in coronary perfusion in order to maintain roughly constant flow. From a myogenic
point of view, the vessel stretching caused by the increased pressure leads to the depolarisation
of the cells and subsequent vasoldilation [13]. Metabolic mechanisms of autoregulation are
also at play and stem from the coupling between metabolic activity and blood flow. Hypoxia, a
oxygen deficiency, is known to cause vasodilation as it leads to the release of adenosine, which
relaxes the vessels. Hypoxia is also thought to open adenosine triphosphate-sensitive potassium
(K+) channels and the increase in interstitial K+ dilates the vessels [14].
2.3 Ischaemic heart disease
Myocardial ischaemia is the process ensuing when coronary blood flow fails to meet the
muscles oxygen and nutrient requirements. The tissue becomes hypoxic and if sustained can
undergo irreversible cell necrosis, known as a myocardial infarction or more commonly, a heart
attack.
As discussed, ischaemia does not occur under ideal, healthy conditions due to the elegant
coupling between oxygen requirements and coronary blood flow. However, such ideal condi-
tions are not guaranteed and in particular are precluded by the atherosclerosis of the coronary
arteries. The cholesterol-rich plaque, atheroma, builds up naturally over time in the vessels,
though it can be significantly accelerated by lifestyle choices. This build-up can lead to a
reduction in blood flow known as ischaemic heart disease (IHD) or coronary artery disease
(CAD). Cardiovascular disease (CVD), of which CAD is the most prevalent, is the leading
cause of death globally. It accounted for an estimated 17.9 million deaths in 2016 and there is
expected to be more hospitalisations and deaths as the population ages, particularly in western
countries [15].
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The increased pressure caused by the lumen narrowing can be well regulated under resting
conditions. It could be that even for moderately narrowed vessels, the increased resistance in
the vessel can be offset by distal vasodilation [7]. However, for significantly narrowed vessels,
coronary blood flow or perfusion (which are used synonymously in this thesis) will be reduced.
The problem is exacerbated during stress or exercise as increased flow is required but the distal
vasodilation is not sufficient to achieve this. The effect of a single stenosis on the myocardium
can be particularly pronounced due to the limited flow between branches of the coronary tree
[7]. The result being that most of the tissue downstream of a stenosis will be affected.
Angina (pectoris) is the term used to describe the chest pain associated with myocardial
ischaemia and is in nature either stable or unstable. Stable angina is typically absent at rest
and increases with increasing stress or physical exertion. Unstable angina is less predictable. It
can be caused by the built-up plaque rupturing and forming blood clots which cut off flow [16].
This may be unrelated to physical exertion and there may have been no prior warning.
The damage associated with myocardial ischaemia can be reversed if the oxygen deprivation
is transient. However, if sustained for a period of time, the ischaemia will lead to a myocardial
infarction. The oxygen deprivation does not instantaneously lead to cell necrosis, rather it
triggers a series of predictable events, commonly referred to as the ischaemic cascade. The
series of events, shown in Figure 2.4, begins with reduced perfusion which will in turn lead to











Fig. 2.4 A schematic representation of the ischaemic cascade
The ischaemic cascade is central to any discussion on the diagnosis of CAD as earlier
diagnosis (and treatment) is known to improve outcomes [17]. While traditional clinical
assessment is concerned with angina and ECG changes, as will be discussed in this thesis,
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state-of-the-art imaging techniques are focussed on identifying earlier and earlier markers of
CAD.
Myocardial infarctions are classified based on their effect on the electrocardiogram (ECG)
of the patient. An elevation of the ST segment of the ECG can be caused by a thrombus,
a completely blocked lumen leading to transmural ischaemia and a so-called ST-elevation
myocardial infarction (STEMI) [18]. Non-transmural ischaemia can lead to a non ST-elevation
myocardial infarction (NSTEMI), this is typically less dangerous as it affects less of the
myocardium.
The result of an infarction is that the tissue forms a fibrotic scar [19]. This non-viable tissue
has a reduced ability to conduct electrical activity and results in the ventricles being unable to
contract properly. The impaired ventricular function causes a reduction in cardiac output and
can progressively lead to heart failure [16].
2.4 Imaging coronary artery disease
Imaging for the diagnosis of CAD follows two main directions: anatomical imaging and
functional imaging. Anatomical imaging is focused on the visualisation of the coronary
arteries and the narrowing thereof. Functional imaging assess the functional significance of
the narrowing arterial lumen. Functional tests are usually performed during stress in order to
induce perfusion or wall motion abnormalities. The ideal test would, as well as being both
sensitive and specific, be safe. With this in mind, non-invasive imaging is preferable as it
reduces the risk of adverse advents as a result of the testing and the test ideally would limit the
patient’s exposure to ionising radiation. In order to maximise the sensitivity of the test it would
be desirable for the test to probe effects that are observable at early stages of the ischaemic
cascade. In particular, with regards to the functional testing, the ability to detect subtle effects at
earlier stages of disease is advantageous and requires either high spatial or temporal resolution.
The history of CAD imaging began with the use of anatomical imaging and then progressed
towards the use of functional imaging to diagnose CAD earlier. However, there has been a
recent move back towards anatomical imaging, especially in order to rule out CAD. This is
based on the argument that even after an abnormal functional test, some form of anatomical
imaging is required to confirm the diagnosis of CAD. However, as discussed, this does not
provide information on the haemodynamical consequences of the disease and indeed the future
probably lies in a combined functional and anatomical assessment.
The following subsections will detail the available forms of CAD testing and include a brief
discussion of their respective pros and cons.
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2.4.1 X-ray coronary angiography
The coronary angiography is considered to be the gold standard for the diagnosis of CAD [20].
Catheters are inserted into the patients arteries through either the radial or femoral artery and
guided to the ascending aorta. An iodine-based radio-opaque contrast agent is then injected in
order to visualise the blood vessels and potential narrowings on the X-ray images. While the
test is highly diagnostic, the major downsides of the procedure are the risk of complications,
including puncturing a vessel, the use of ionising radiation, and the discomfort caused to the
patient.
There are further benefits to the approach. It is possible to derive quantitative measures
such as the fractional flow reserve (FFR). For this, a pressure sensor is used on the tip of
the wire inserted and the FFR value is computed as the ratio of the pressures measured in
the aorta and immediately downstream of a lesion. Furthermore, upon the identification of
a haemodynamically significant lesion, it is possible to treat it with a stent or a balloon in a
procedure known as percutaneous coronary intervention (PCI).
2.4.2 Electrocardiogram
The ECG monitors the electrical activity in and around the heart. As previously discussed,
myocardial infarctions can alter the way that the heart conducts electrical activity and this can
be observed on an ECG. Since the test is cheap and safe, it is often one of the first assessments
that a patient receives [21]. The limitation of the ECG is that the changes in electrical activity
only occur at an advanced stage of the ischaemic cascade, though ischaemia can be detected
earlier under exercise stress.
2.4.3 Echocardiogram
The echocardiogram (echo) is a cardiac ultrasound and uses a transducer to send and receive
ultrasound beams to allow the visualisation of cardiac anatomy. It provides a quick and easy
assessment of cardiac structures, wall motion, and, using Doppler-based imaging, even blood
flow [22]. An echo is cheap, free from ionsing radiation, and the devices can be brought to a
patients bedside. As a result, it is the most commonly performed imaging assessment of the
heart [21]. The main limitations to the general applicability of echocardiography in clinical
practice are that the image quality depends on the anatomy and acoustic window of the patient,
the positioning of the transducers, and the skill of the operator. The images can suffer from a
significant amount of speckle noise and may, thus, not be of diagnostic quality. Furthermore,
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the wall motion abnormalities probed by the test also only manifest themselves at a late stage
of the ischaemic cascade.
2.4.4 Single-photon emission computed tomography
SPECT is one of the most commonly used cardiac imaging techniques. It is a particularly
important imaging modality to consider as it can assess myocardial blood flow [23]. This is
crucial for the early diagnosis, and to guide the management, of patients with CAD as impaired
perfusion occurs early in the ischaemic cascade. SPECT counts the number of photons emitted
in an area (and thus the amount of radioisotope accumulated), this is assumed to be proportional
to blood flow in the tissue. The imaging is typically carried out with the use of vasodilator
stressor agents in order to identify stress-inducible ischaemia.
The major limitation of the modality is that the spatial resolution achievable is typically on
the order of 10mm3. This makes it difficult to identify regional perfusion abnormalities and
the images are subject to motion and partial volume effects. Additionally, long imaging times
required to record sufficient signal and the photon emitting radioisotopes injected typically
have long half-lives meaning significant exposure to ionising radiation for the patient [23].
2.4.5 Positron emission tomography
PET is, in principle, similar to SPECT except that the radiotracers are labelled with positron
emitting isotopes. The signal recorded, by an array of detectors around the body, is from
the gamma rays emitted when the positrons collide with the electrons in the tissue [21].
Metabolism can be quantified in absolute terms and it is also possible to derive quantitative
values of myocardial blood flow (MBF) in units of millilitres per minute per gram of tissue
(ml/min/g) [24]. The quantitative values easily identify areas of ischaemia while the patient is
stressed. The array of detectors yield superior spatial resolution to SPECT and furthermore,
the short half-lives of the radiotracers used, as compared to SPECT, means less exposure to
ionising radiation for the patient. However, the amount of radiation and spatial resolution are
still limiting.
2.4.6 Computed tomography
Computed tomography (CT) has developed into an emerging technology in the application of
non-invasive CAD diagnosis. In particular, coronary CT angiography (CCTA) facilitates the
visualisation of the coronary arteries and the National Institute for Health and Care Excellences
(NICE) guidelines also include fractional flow reserve derived from CCTA (FFRct). FFRct can
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determine the functional significance of a lesion [25]. Recent improvements in CT detector
rows have made it possible to test for ischaemia using dynamic stress perfusion CT [26].
However, this is yet to see widespread adoption due to concerns about the radiation dose,
technical difficulties leading to motion artefacts, a low contrast-to-noise ratio, quantification
challenges, and a lack of availability [27].
2.4.7 Cardiovascular magnetic resonance
Magnetic resonance imaging (MRI) is a hugely versatile imaging modality and CMR has the
potential to overcome many of the limitations of the imaging modalities discussed so far. In
particular, myocardial perfusion MRI, the subject of this thesis, has emerged as a sensitive and
specific ischaemia test. The benefits of myocardial perfusion MRI over the other ischaemia tests
discussed are that it is free from ionising radiation and gives high spatial resolution. Perfusion
is typically assessed with dynamic contrast-enhanced imaging, using a Gadolinium-based
contrast agent.
The MR-IMPACT II trial showed perfusion MRI to have a similar diagnostic accuracy to
SPECT in a multi-centre setting [3] and similarly the CE-MARC trial found multi-parametric
CMR to be more accurate than SPECT for the diagnosis of coronary artery disease [2]. While
the CE-MARC 2 trial showed CMR imaging is associated with a lower probability of un-
necessary coronary angiography than SPECT imaging without an increase in major adverse
cardiac events (MACE) [28]. It further found that functional testing outperformed anatomical
tests with respect to the endpoint of unnecessary angiography. Recently, the MR-INFORM
(MR perfusion imaging to guide management of patients with stable coronary disease) study
randomised 918 patients with typical angina to either FFR-guided management or perfusion
CMR-guided management [4]. It found perfusion CMR to be non-inferior to FFR for the
management of patients with respect to major adverse cardiac events. Additionally, it found that
a perfusion MRI-guided approach significantly reduced the number of unnecessary coronary
revascularisations. Further adding to the evidence supporting the use of perfusion CMR, the
SPINS (stress CMR perfusion imaging in the United States) study retrospectively analysed
data from the Society for Cardiovascular Magnetic Resonance (SCMR) registry. In this cohort
of nearly 2500 patients across 13 centres, the SPINS study showed the long-term prognostic
performance of perfusion MRI in a real-world setting [29]. It also showed the costs benefits of
CMR as a gate-keeper test: very low downstream costs for ischaemia testing were reported for
patients after negative CMR tests.
Further to the evidence presented, the unique selling point of perfusion CMR may be
that it can be incorporated easily into a comprehensive CMR examination. The modality’s
wide-ranging utility has led to it being described a "one-stop shop" for the assessment of
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ischaemic heart disease [30]. In a single examination, it is possible to image ventricular
function, myocardial ischaemia using stress perfusion imaging and myocardial viability using
late gadolinium enhancement. In the coming years, further technical development will also see
CMR be used more frequently for the visualisation of the coronary arteries [31].
Despite all the apparent benefits of stress perfusion CMR, it is still not common place in
clinical practice. Thus far, all evidence has been accumulated at expert tertiary centres where
there is a vast experience of performing and reporting the scans. One of the reasons limiting the
widespread clinical adoption is that there is limited data supporting its use at less specialised
centres. The reading of the scans is complex and time consuming, and there is little access to
training. A recent study by Villa et al. [5] showed the diagnostic accuracy is highly dependent
on the level of training of the reader.
This serves to highlight the need for an objective, user-independent assessment of ischaemia
and in particular, the quantitative analysis of stress perfusion CMR. Quantitative measures of
myocardial perfusion have the potential to add the benefits of speed, automation, and repro-
ducibility to a test which is already known to be accurate, non-invasive, and free from ionising
radiation. The quantitative values also add independent prognostic value [32, 33]. However,
quantitative perfusion CMR is still hindered by technical difficulties such as respiratory motion,
the time-consuming nature of the image processing, and questions about the reliability of the
quantitative values. The solutions to these challenges will be discussed in detail in this thesis.
Chapter 3
Myocardial perfusion MR imaging
The chapter will introduce the basic concepts of MRI and how these relate to the imaging
of myocardial perfusion. It will then discuss the theory underlying the quantification of
myocardial perfusion: the tracer-kinetic modelling, parameter inference, and arterial input
function estimation. The chapter concludes with a review of the state-of-the-art in quantitative
myocardial perfusion.
3.1 The basics of MRI
MRI is based on the principle of nuclear magnetic resonance (NMR). NMR is the effect exerted
on nucleons with non-zero angular spin when exposed to a magnetic field. Atoms with an odd
mass number (an atoms mass number is the total number of protons and neutrons in its nucleus)
have half-integer spin and this spin is aligned in the presence of an external magnetic field B0.




where γ is the gyromagnetic ratio. γ = 2.675 radT−1 s−1 for the hydrogen atom (1H) which is
the most frequently used atom in MRI as it is omnipresent in the human body. Typically, we
are considering an ensemble of spins rather than a single spin with M then being the sum of
magnetisations. In the absence of external forces this will be zero as the spins are pointing in
all different directions.
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In a static B0 field, the magnetisation precesses at a frequency dependent on the magnitude
of B0, known as the Larmour frequency:
ω0 = γB0. (3.2)
With the introduction of a radiofrequency (RF) excitation pulse B1, M can be flipped from
its equilibrium state M0 into the transverse plane. The B0 field is typically thought of as
being aligned with the z axis, the longitudinal component, and thus the transverse plane is the
x–y plane. The flip angle is given by α = γB1∆t, with ∆t being the duration of the RF pulse.
M will begin to return to its equilibrium state after the RF pulse is finished and the temporal



















T1 and T2 are the longitudinal and transverse relaxation constants, respectively. The transverse
magnetisation decays exponentially with time constant T ∗2 and simultaneously, the longitudinal
magnetisation returns exponentially to its equilibrium state with time constant T1. T ∗2 is a
longer decay constant which incorporates the additional transverse decay due to magnetic field










It is the differences between these relaxation constants, due to the local molecular environment
of tissue, that gives different contrasts between tissues and allows us to generate images. The
specific sequence of RF pulses and gradient pulses played to achieve the required MR signal is
known as the pulse sequence.
3.2 Introduction to myocardial perfusion CMR
The most common approach to the assessment of myocardial perfusion using MRI is with
dynamic contrast-enhanced (DCE) acquisitions, as was first described more than 30 years
ago [34]. This is done with paramagnetic contrast agents, the most common of which are
gadolinium-based. Gadolinium is highly paramagnetic due to its 7 unpaired electrons [35] and
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thus the hydrogen nuclei close to the gadolinium will have reduced relaxation times. The T1
relaxation time of the water protons is inversely proportional to the concentration of gadolinium
[36]:
R1 = R10 + r1[Gd] (3.7)
where R1 = 1/T1 is the longitudinal relaxation rate, R10 is the pre-contrast longitudinal re-
laxation rate, r1 is the relaxivity of the contrast agent (4.5 lmmol−1 s−1 for gadovist at 3T
[37]), and [Gd] is the concentration of gadolinium. Thus, areas with a high concentration of
gadolinium will appear to be brighter on T1 weighted images. In perfusion CMR, a bolus of
contrast agent is administered intravenously and time dynamic images are acquired to observe
the temporal evolution of the contrast bolus. Areas of the myocardium with reduced perfusion
hence appear hypointense. These perfusion defects correspond to regions of either ischaemia
or fibrosis [38].
As discussed in Section 2.2, the principle of autoregulation ensures that for even a relatively
large coronary artery stenosis there may be no reduction in myocardial blood flow. For this
reason, scans are usually acquired at peak, pharmacologically induced, vasodilation such that
autoregulation can no longer account for the stenosis. Since exercise is not feasible in the
scanner, vasodilator stress is pharmacologically induced. This is typically done with adenosine
which causes flow-mediated vasodilation [39]. Rest images may also be acquired to check for
scar or to account for artefacts.
To ensure coverage of the LV, 3 slices are typically acquired in a short-axis view using the
’three-of-five’ rule [40] where 5 slices are planned with equal slice gap from the base of the LV
to the apex and the middle 3 slices are used, demonstrated in Figure 3.1.
Fig. 3.1 Initially five slices with equidistant gaps are planned and the middle three slices (shown
in green) are used.
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The most commonly used pulse sequence for perfusion CMR is a 2D multi-slice saturation
recovery (SR) sequence [38]. A 90° saturation preparation pulse is used to null the pre-contrast
signal and to hence visualise the passage of the contrast bolus. Inversion recovery (IR) rather
than SR sequences have also been proposed. In this case the 180° preparation pulse inverts the
magnetisation to maximise the dynamic contrast-enhancement. The limitations of IR sequences
are the increased imaging time makes it incompatible with high heart rates. IR sequences
also makes the contrast dependent on the duration of the R-R interval, which is undesirable
in patients with varying heart rates, such as in cases of arrhythmia [41]. The acquisition is
ECG-gated, images are acquired a fixed time (trigger time) after the R wave is recorded to the
effect that the slices are always acquired in the same cardiac phase [38].
At 3T, the most commonly used readout are spoiled gradient echo readouts. These re-
peatedly excite the imaging slice with pulses of low flip angle while acquiring k-space data
line-by-line. The excitation pulses are with low flip angles to allow rapid imaging, larger flip
angles would give more T1 contrast but would not be possible within a single R-R interval.
Balanced steady-state free precession (bSSFP) and echo planar imaging (EPI) readouts are also
used but are less commmonly employed.
More recently, 3D [42] and simultaneous multi-slice acquisitions [43] have been proposed
in order to increase the coverage of the LV but these are not widely available and have not yet
achieved clinical adoption.
Non-contrast alternatives for myocardial perfusion imaging include arterial spin labelled
(ASL) and blood oxygen level-dependent (BOLD) CMR. ASL employs RF pulses to locally
alter the magnetisation of the arterial blood supply and then images the labelled blood as it
reaches the myocardium in order to estimate perfusion [44]. BOLD uses deoxyhaemoglobin as
an endogenous contrast agent. Since deoxyhaemoglobin is paramagnetic, it reduces the signal
in T2-weighted images and thus gives a direct assessment of myocardial oxygenation and blood
flow [45]. Both approaches have some limited clinical data supporting their use but they still
remain research tools. As such, this thesis will focus solely on DCE perfusion CMR.
As discussed, due to its high diagnostic accuracy, stress perfusion CMR has become one
of the methods of choice for the diagnosis of CAD. It has a class IA recommendation from
the European Society of Cardiology (ESC) for the evaluation of patients with an intermediate
pretest probability of CAD [46]. The main limitation of the modality is the difficulty of
interpreting the images. The diagnostic accuracy has been shown to be highly dependent on
the level of experience of the operator [5]. The difficulty of the interpretation of the images
is visualised in Figure 3.2 which shows the same image with different levels of contrast
windowing. The identification of perfusion defects, as indicated by the arrows, changes with
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different windowing. A potential solution to this is the quantitative analysis of the images which
would add user-independence and reproducibility to the high clinical utility of the modality.
Fig. 3.2 An example image demonstrating the difficulty of the visual assessment of perfusion
CMR. The diagnosis of the patient from one-vessel disease (orange arrows) changes to two-
vessel disease (orange and yellow arrows) with the narrowing of the contrast window. At an
intermediate level of windowing (centre), the diagnosis is not clear.
3.3 Quantitative myocardial perfusion CMR
The goal of quantitative myocardial perfusion CMR is to infer the kinetics of the myocardium
from the observed signal (contrast) evolution. The quantification of these tissue properties give
a high level of diagnostic information about the patient.
3.3.1 Signal intensity to contrast concentration conversion
The first challenge in this process is the conversion of the MR signal intensities (SI) to the
concentration of the contrast agent, gadolinium [Gd] (in units of M). In the ideal case, there
is a linear relationship between SI and [Gd]. As will be shown in Section 3.3.2, the tracer-
kinetics are modelled as a linear time-invariant system so that, in the case of linear relationship,
the parameter estimates derived with the SI curves directly are equal to those derived with
the concentration curves. The reality, however, is that there is a more complex, non-linear
relationship between SI and [Gd] [47] causing a signal saturation for high [Gd] [48]. As a
result, the relationship between SI and [Gd] needs to be modelled. This is done by estimating
T1 at each time from the corresponding SI and relating T1 to [Gd] through equation 3.7. The
signal equation, as a function of T1, for a saturation-recovery spoiled gradient echo sequence,
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as commonly used in perfusion CMR, is given as:
S = ψS0
[





where ψ is a constant scaling factor that absorbs factors such as the coil sensitivities and system
gains, S0 is the baseline signal level, TSAT is the time between the saturation preparation pulse
and the acquisition of the central line of k-space, TR is the repetition time between excitation
pulse, a = cosα exp(−TR/T1), α is the flip angle and n is the number of excitation pulse from
the beginning until the centre of k-space [47]. ψ is assumed to be constant over time and can
be estimated from the baseline pre-contrast images using a baseline T10. Since S = ψ f (T1), the
estimated ψ is given as ψ = f (T10)/S0. The baseline T10 can either be taken from literature
values or from a pre-contrast T1 map. The T1 value at each time point is then determined using
a root-finding algorithm.
3.3.2 Tracer-kinetic modelling
In theory, the gadolinium-based contrast agents used in perfusion CMR are indicators rather
than tracers as they are not chemically the same as the systemic substance of interest [49].
Nonetheless, the word tracer will be used in order to maintain consistency with the literature.
General theory
A tissue is modelled as system with a series of inlets and outlets through which the system
substance can flow. The models are built on the theory of linear time-invariant systems [50].
That is, that the transit time, the time elapsed between entering and leaving the system, does
not depend on the time of the contrast injection or the injected concentration. The system is
governed by the conservation of mass. This states that no tracer is created or destroyed in the
system and gives that the rate of change of concentration in the tissue is the difference between









where v is volume of distribution (the volume of the system that contains the tracer), C(t) is
the total concentration of tracer in the system and, Fi,Fo and Ci(t),Co(t) are the flows through
and concentrations at the inlets i and outlets o of the system. The system itself can be made up
of a number of interacting compartments with the inlets of a compartment possibly being the
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outlets of another compartment. Equation 3.9 can be applied to each compartment to yield a
system of n ordinary differential equations (ODEs).
Two-compartment exchange model
In the myocardium, there is a single arterial input and single outlet. The tracer is assumed
to be contained in the blood plasma and the extravascular extracellular space (EES) and that
each of these spaces are an individual compartment. This gives rise to, under some further
assumptions, to the two-compartment exchange model (2CXM) [51]. The further assumptions
made are that the influx and outflux of the system is through the plasma compartment, the EES
compartment only exchanges with the plasma compartment, and that this exchange is equal
in both directions. This then gives two coupled ODEs for the concentration of contrast in the
Fig. 3.3 A visualisation of the underlying physiological representation of the 2CXM.








= PS · (Cp(t)−Ce(t)). (3.11)
In these equations, CAIF(t) (M) is the arterial input function (AIF), the assumed input to the
system that is being modelled. Fp is the plasma flow (ml/min/ml) , vp is the fractional plasma
volume (dimensionless), ve is the fractional interstitial volume (dimensionless) and PS is the
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permeability-surface area product (ml/min/ml). The total concentration of contrast in the
myocardial tissue is then given as the weighted sum of the concentration in the compartments:
Cmyo(t) = vpCp(t)+ veCe(t). (3.12)
The 2CXM can be modified by making additional assumptions that the system contains
only one compartment or that there is uptake of contrast rather than exchange of contrast in the
tissue [50]. It can further be extended to include a spatial component, i.e to assume that the
concentration of contrast is not uniformly distributed over a compartment.
In this thesis, the 2CXM will be the focus as it balances most closely matching the
underlying physiology while still having an analytic solution.
Solution of the two-compartment exchange model
An analytic solution for Cmyo(t) can be obtained using the Laplace transform under the assump-
tion of zero initial concentration Cp(t = 0) = 0 and Ce(t = 0) = 0. In the Laplace domain, the
coupled ODEs in equations 3.10 and 3.11 become:
vpC̃p(s) = Fp · (C̃AIF(s)−C̃p(s))+PS · (C̃e(s)−C̃p(s)) (3.13)
veC̃e(s) = PS · (C̃p(s)−C̃e(s)) (3.14)





which can be substituted back into equation 3.13 to give:


















3.3 Quantitative myocardial perfusion CMR 22
Similarly,
C̃e(s) = Fp ·C̃AIF(s)
PS
vpve









Hence, the total tissue concentration in the myocardium can be written in Laplace space as:














It is observed that the denominator of equation 3.20 is a quadratic function of s and that its



























and so by the use of partial fractions equation 3.20 can be rewritten as:















α−β . The inverse Laplace transform then yields the time domain solution:
Cmyo(t) = Fp ·R(t)∗CAIF(t) (3.23)
with:
R(t) = Aexp(αt)+(1−A)exp(β t) (3.24)
being the residue function which can also be written as R(t;θ) to emphasise its dependence on
the kinetic parameters θ = (Fp,vp,ve,PS). The solution given by Equation 3.23 is shown in
terms of the concentration curves in Figure 3.4.
The model, as derived, considers the plasma compartment and hence the plasma flow and
plasma volume parameters. Since the convention is to report blood flow and blood volume
parameters a conversion can be made using the blood haematocrit value Fb = Fp/(1−Hct) and
vb = vp/(1−Hct). The AIF, which is sampled from the LV cavity, is converted from arterial
blood concentration to arterial plasma concentration by substituting CAIF(t)/(1−Hct) for
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CAIF(t). Patient specific haematocrit values could be used but they are not typically available
and a literature reference of Hct = 0.45 is used [37]. Flow values are converted from units
of ml/min/ml to its mass equivalent ml/min/g by multiplying by the specific density of the
myocardium, taken as 1.05 gml−1. Note that Fb is often referred to as myocardial blood flow
and will be used interchangeably with the acronym MBF.
Residue Function Arterial Input FunctionMyocardial Tissue Curve
Myocardial perfusion quantification
=
Fig. 3.4 The myocardial tissue curves is shown as the result of a convolution of the AIF with a
residue curve.
Kinetic parameter estimation
The most common approach to the estimation of the model parameters from observed my-
ocardial and arterial concentration curves is using non-linear least squares fitting [52] with the
most popular choice of fitting algorithm being the Levenberg–Marquardt approach [53]. That
is to say, the sum of squared errors between the analytic solution for Cmyo and the observed
myocardial tissue concentration curves is minimised with respect to θ . The parameters θ̂ giving




This process is sometimes (incorrectly) referred to as a deconvolution.
The ability to accurately estimate θ can depend on the quality of the data. The data quality
can be limited by the signal-to-noise ratio (SNR), the acquisition time, the temporal resolution,
and artefacts, such as motion [52]. These introduce local optima in the cost function. This
means that there are distinct sets of parameters that are indistinguishable at the noise level
present in the data [6]. The result of this is that the parameter estimates obtained from the
non-linear least squares fitting algorithm are highly dependent on the initial starting point of the
optimisation. Ahearn et al. [52] reported that repeating the optimisation with multiple different
starting points can improve the reliability but still is far from perfect even using simulated data
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without noise. Buckley [6] found an array of local minima in which different combinations
of parameters give very similar solutions, while Jerosch-Herold et al. [54] were unable to get
unique estimate for Fp.
The reliability of the estimated parameters can also be improved by reducing the complexity
of the model used [6]. As mentioned, other choices of model are possible. Examples of models
commonly employed for myocardial perfusion quantification are the Kety-Tofts model [55]
and the Fermi model [54]. These models have fewer parameters to estimate, making the fitting
problem more stable. However, they have limitations in that the Kety-Tofts model does not
resolve directly for Fp and the Fermi model is not physiologically motivated. Alternatively,
approaches for improving the parameter estimates with the 2CXM include fitting to a concen-
tration curve averaged over a whole segment of myocardium. This sacrifices resolution in order
to increase contrast-to-noise (CNR). However, it is well known that high resolution maps are
needed for detecting subtle ischaemia [56].
This motivates the need for more robust fitting approaches, as will be discussed in Chapter
6.
Arterial input function
The accurate estimation of the AIF is one of the key challenges of myocardial perfusion
quantification. In theory, the AIF should be sampled from the inlet of the system. In the case of
myocardial perfusion CMR this would be the root of the aorta. However, this is not typically
imaged in a standard perfusion CMR acquisition and those the AIF is sampled from the LV. An
example image with the sampling locations of is shown in Figure 3.5. The effect of sampling
in the aorta rather than the LV would be a delay and dispersion in the AIF [57]. The delay can
be accounted for by replacing CAIF(t) with CAIF(t− τ) where τ is the delay and can either be
fit as an extra model parameter or estimated separately. The dispersion could also be modelled
and accounted for [57], though this is not done in perfusion CMR and leads to a systematic
under-estimation of perfusion.
Since the whole bolus of contrast passes through the LV cavity more-or-less simultaneously,
very high concentrations of contrast agent are recorded at the peak of the AIF. As a result, the
relationship between the signal intensity and contrast concentration in the AIF is non-linear
[58]. Conversely, as only a small fraction of the total amount of the contrast inject perfuses a
particular area of myocardium, the concentration remains low and a linear relationship between
signal intensity and contrast concentration is assumed to hold.
As discussed, the contrast concentration can be estimated from the AIF SI using Equa-
tion 3.8. However, this fitting suffers from the same difficulties that were discussed in
Section 3.3.2 and it would beneficial if a linear relationship could be assumed so that the
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Fig. 3.5 The AIF (red, left) and myocardial tissue curve (blue, right) shown with their corre-
sponding sampling locations overlaid on the MR image (centre).
tracer-kinetic modelling could be performed directly using the relative signal enhancement






For this reason, a significant amount of effort and research in methods for myocardial
perfusion quantification is focused on approaches for approximating a linear relationship
between signal intensity and contrast concentration in the LV cavity. There are currently two
approaches for doing this: the dual-bolus approach and the dual-sequence approach.
The dual-bolus approach uses a low-dose bolus (the pre-bolus) of contrast agent (typically
1/10th of the full dose) in attempt to avoid the signal saturation at high contrast concentrations
[48]. This low dose, for AIF estimation, does not yield enough signal to assess the myocardium
so it is then followed by a full dose (the main bolus). For the tracer-kinetic modelling, the AIF
from the pre-bolus is scaled up (by 10) to approximate the main bolus without signal saturation
and used with the myocardial curves from the main bolus. The dual-bolus method is well
validated and has proven to give accurate estimates of perfusion [60–62]. However, its clinical
adoption has been limited due to the complexity added to the scan and the extra work involved
in the two injections.
The dual-sequence method acquires an extra low resolution image slice with a short
saturation-recovery time to minimise the saturation of the AIF signal [63]. The benefit of the
dual-sequence is that perfusion can be quantified accurately with a single bolus of contrast.
The clinical adoption has been slow as the sequence has yet to be commercialised and made
available on all scanners. However, recent implementations of research prototypes are making
the sequence more widely available [58, 64]. The limitation is that the extra image slice adds
additional time to the acquisition, at high heart-rates it, therefore, may not be possible to
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acquire all slices in one cardiac phase and the spatial resolution may have to be compromised.
Furthermore, while the short saturation time minimises the signal saturation, it may not
completely prevent it.
Recent work has demonstrated that since there is an extra image required for the dual-
sequence approach that it is feasible to not collocate this with the myocardial slices [65].
Mendes et al. chose to place the AIF slice in the ascending aorta which should be more accurate
in theory, though further research is required to fully explore this direction.
3.4 Literature review
There is a wealth of literature on methods, evaluation, and validation of quantitative perfusion
CMR. A lot of the early work focused on the use of semi-quantitative metrics where, in lieu of
the full tracer-kinetic modelling, the ratio of the up-slope in the myocardial tissue curves to the
up-slope in the AIF is used as a surrogate for flow. This has been validated versus coronary
angiography [66–68] and FFR [69] with favourable accuracy as compare to visual assessment.
It has been further compared to the non-invasive reference standard for perfusion quantification,
PET, showing a good correlation between the methods [70, 71]. Al-Saadi et al. [72] used a
training set to derive a cutoff for ischaemia and applied the threshold obtained prospectively to
a new cohort and found a diagnostic accuracy of 87% for the detection of a significant stenosis
on the coronary angiogram.
The limitation of the semi-quantitative measures is that they are not physiological and
as such are subject to variations across patients, scanners, and implementations. The wide
variations in absolute values motivated the use of the myocardial perfusion reserve (MPR)
instead of the absolute values. The MPR is the ratio of flow at stress to flow at rest and the
idea is that the variations may cancel themselves out in the ratio. This is not really the case
and, indeed, Mordini et al. [73] showed superior diagnostic performance for fully-quantitative
perfusion over the semi-quantitative measures. Furthermore, there is a recent trend towards
stress only imaging to reduce scan time and thus MPR is no longer possible and absolute
quantification of stress perfusion is desired.
Other semi-quantitative measure have also been developed. Hautvast et al. [74] computed
gradients in the signal-intensity curves in the transmural direction, across the myocardial wall.
This built on the knowledge that perfusion defects appear earlier and more severely in the
sub-endocardial wall. Chiribiri et al. [75]. used the temporal dyssynchrony of flow in the
myocardium. This is effective at detecting CAD as a coronary artery stenosis causes temporal
delays and dyssynchrony in the contrast flow, while contrast flow is temporally uniform in the
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absence of a stenosis. While both approaches showed promising performance, neither has seen
widespread adoption.
More recently, much of the focus in the field has been towards fully-quantitative perfusion
CMR. This has again been compared extensively to PET perfusion estimates [76–78]. All of
these studies found a strong linear correlation even if the absolute values do not agree perfectly
due to the differences in the quantification methods. Similarly, two studies have found a high
correlation between perfusion quantified by CMR and by fluorescent microspheres in dogs [60]
and pigs [62]. This indicates that quantitative perfusion CMR is indeed accurately estimating
flow and paves the way for its use in the clinic.
There has been further validation versus invasive measurements in patients with CAD.
Lockie et al. [79] reported an area under the curve (AUC) of 0.89 on the receiver operating
characteristic (ROC) analysis versus FFR. This matched the accuracy of the expert visual
assessment. Similar accuracy in comparision to invasive measurements was reported in a series
of further studies [59, 80–82]. Out of these, importantly, Papanastasiou et al. [80] reported
superior diagnostic accuracy using a full tracer-kinetic model rather than the Fermi function
approximation and they also, along with Biglands et al. [81], found no benefit of including the
rest results in addition to the stress perfusion values. Sammut et al. [32] took all of this a step
further and showed the prognostic value and in particular that the ischaemic burden computed
by quantitative perfusion CMR predicts adverse cardiac events.
The focus on quantitative perfusion may seem disproportionate considering that none of the
aforementioned studies show that it outperforms the visual assessment. However, it should be
noted that all of the studies were conducted at very experienced research hospitals. Villa et al.
[5] showed that the performance of the visual assessment drops off quickly for less experienced
operators. The hypothesis is that quantitative perfusion is less user-dependent than the visual
assessment that it could more easily generalise to less experienced centres.
The drawback of all the studies is that the quantification still involved tedious manual
interaction for the selection of the AIF, segmentation of the myocardium, motion correction,
and time delay estimation. For example, Biglands et al. [81] reported that it took one hour per
patient to manually correct the myocardial segmentation to fit the motion in the data which is
not feasible in clinical routine. This motivates the aim of this thesis, to build and validate a
fully-automatic pipeline including robust motion compensation and more reliable estimates of
the kinetic parameters, negating some of the problems discussed in Section 3.3.2.
There has been other work developed concurrently or after the work presented in this thesis.
Xue et al. [83] presented an automated pipeline using their dual sequence implementation [64].
This was compared to PET in a semi-automated approach which automatically generated pixel-
wise flow maps but required manual segmentation of myocardium and its sub-segmentation
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[84]. Finally, they also demonstrated the prognostic value of quantitative perfusion CMR in a
study which included automatic segmentation [33].
Chapter 4
Robust non-rigid motion compensation of
free-breathing myocardial perfusion MRI
data
4.1 Preface
The reliable quantification of myocardial perfusion on a pixel-wise level assumes that the
myocardium remains stationary over time. This is of course not realistic as the heart is
contracting and the patient is breathing. Cardiac motion is well accounted for in perfusion
CMR as the acquisition are ECG-triggered so that a slice is always imaged in the same cardiac
phase. However, respiratory motion can cause inter-frame misalignment. The effect of this
inter-frame misalignment on the myocardial tissue curves is shown in Fig 4.1 which can lead to
errors in the tracer-kinetic modelling.
The most common way to minimise respiratory motion is breath-holding but since typical
scans are longer than a minute, the breath-hold cannot cover the full scan. This is especially
true for patients with heart disease who have trouble breathing and breath-holding. Long breath-
holds also induce changes in heart rate and, thus, cause images to be acquired at different
cardiac phases [85]. For visual assessment, a short breath-hold around the time of the first-pass
of the contrast bolus through the myocardium is sufficient. However, this is not the case for
tracer-kinetic model fitting, particular for accurately identifying the microvascular kinetics
which play out at longer time scales.
Motion compensation techniques are based on using image registration to correct the
inter-frame misalignment. Mathematically, this is to define a cost function C describing how
dissimilar an image Ii is from a reference image Ri and to find the transformation Ti from the
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The problem of respiratory motion
Fig. 4.1 The motion profile of myocardial tissue curves before and after motion compensation
taken as the average signal from each of the 6 AHA segments of one myocardial slice.










∀ i = 1,2, . . . ,N (4.1)
where N is the total number of images and E is a regularisation term, to enforce smooth
transformations, controlled by the parameter κ .
The difficulty of applying image registration to perfusion CMR images is the dynamic
contrast-enhancement. The typical cost functions cannot disentangle whether the dissimilarity
in two images is cause by inter-frame misalignment or just by the contrast agent being in a
different location. This work uses robust principal component analysis, which decomposes a
corrupt matrix M into its constituent low-rank L and sparse S components such that M = L+S,
to separate the dynamic contrast-enhancement from the baseline signal. An example RPCA
decomposition for a toy example from [86] is shown in Figure 4.2. A more interesting example
is seen in Figure 4.3 (from [86]) where RPCA is applied to video surveillance data, it is seen
that it well decomposes the video into background (this is low-rank as it remains constant over
time) and foreground (this is sparse as it is constantly changing).
It is perhaps somewhat surprising but such a separation can be easily computed [87] and it
can be formulated as the solution to:
L̂, Ŝ = argmin
L,S
rank(L)+λ∥S∥0 s.t L+S = M. (4.2)
Since the l0 norm, which counts nonzero entries, cannot be easily minimised, it is replaced by
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Fig. 4.2 An example of a RPCA decomposition applied to a toy problem, where it is seen to
decompose a noise corrupted matrix into its constituent low-rank (structure) and sparse (noise)
components [86].
Fig. 4.3 RPCA applied to video surveillance data, where it is seen that the low-rank component
well models the background and the sparse component models the foreground [86].
the l1 norm, which also encourages sparseness [88], leading to:
L̂, Ŝ = argmin
L,S
∥L∥∗+λ∥S∥1 s.t L+S = M. (4.3)
where ∥ · ∥∗ is the sum of the singular values of the matrix and is known as the nuclear norm.
The optimisation is solved using augmented Lagrangian multipliers, in an alternating directions
manner [89]. That is that we iteratively solve the problem for L and S rather than for both
simultaneously. This, intuitively, alternates between soft-thresholding the singular values of L
to encourage low-rankness and soft-thresholding the entries of S to encourage sparseness. With





Xi j− ε if Xi j ≥ εXi j + ε if Xi j < ε (4.4)
this yields the alternating direction method of multipliers (ADMM) for RPCA in Algorithm 1.
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Algorithm 1: RPCA via ADMM
Input : M, λ > 0
Initialise : k = 0, S0 = Y0 = 0, µ > 0
1 while not converged do
2 (U,Σ,V)← svd(M−Sk +µ−1Yk) ;
3 Lk+1← USµ−1[Σ]VT ;
4 Sk+1←Sλ ·µ−1[M−Lk+1 +µ−1Yk] ;
5 Yk+1← Yk +µ(M−Lk+1−Sk+1) ;
6 end
Output : L̂ = Lk, Ŝ = Sk
where svd is the singular value decomposition.
There has been a wide variety of approaches published in the literature in attempt to solve
this problem, as described in part II B of Section 4.2 and in the recent benchmark paper by
Pontre et al. [85]. However, none have gained widespread adoption or are used in clinical
practice, possibly due to a lack of validation and robustness, motivating the need for our reliable
motion compensation scheme.
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38, 1812–1820 (2019). :
Abstract— Kinetic parameter values, such as myocardial 
perfusion, can be quantified from dynamic contrast enhanced 
(DCE-) magnetic resonance imaging (MRI) data using tracer-
kinetic modelling. However, respiratory motion affects the 
accuracy of this process. Motion compensation of the image series 
is difficult due to the rapid local signal enhancement caused by the 
passing of the gadolinium-based contrast agent. This contrast 
enhancement invalidates the assumptions of the (global) cost 
functions traditionally used in intensity-based registrations. The 
algorithms are unable to distinguish whether the differences in 
signal intensity between frames are caused by spatial motion 
artefacts or the local contrast enhancement. In order to address 
this problem, a fully-automated motion compensation scheme is 
proposed which consists of two stages. The first of which uses 
robust principal component analysis (RPCA) to separate the local 
signal enhancement from the baseline signal, before a refinement 
stage which uses traditional PCA to construct a synthetic reference 
series that is free from motion but preserves the signal 
enhancement. Validation is performed on 18 subjects acquired in 
free-breathing and 5 clinical subjects acquired with a breath-hold. 
The validation assesses visual quality, temporal smoothness of 
tissue curves and the clinically relevant quantitative perfusion 
values. The expert observers score of visual quality increased by a 
mean of 1.58/5 after motion compensation and improvement over 
previously published methods. The proposed motion 
compensation scheme also leads to the improved quantitative 
performance of motion compensated free-breathing image series 
(30% reduction in the coefficient of variation across quantitative 
perfusion maps, 53% reduction in temporal variations (p<0.001)). 
 
Index Terms— Image registration, Myocardial perfusion MRI, 
Respiratory motion compensation, RPCA, Tracer-kinetic 
modelling 
I. INTRODUCTION 
IRST-pass myocardial stress perfusion cardiovascular 
magnetic resonance (CMR) has become one of the tools of 
choice for the non-invasive diagnosis of myocardial ischaemia 
[1]–[3]. In current clinical practice, stress perfusion CMR is 
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assessed visually; however, this requires extensive training and 
the diagnostic accuracy depends strongly on the operator [4]. 
As was first suggested more than 20 years ago, it is possible to 
quantitatively analyse myocardial perfusion in units of 𝑚𝑙 ∙
𝑚𝑖𝑛−1 ∙ 𝑔−1  using CMR [5], [6] through the application of the 
indicator-dilution theory [7], [8]. As yet, quantitative analysis 
of perfusion CMR remains primarily a research tool but its 
clinical translation would be advantageous as it can be 
automated [9], [10], enabling accurate and user-independent 
assessment of myocardial perfusion [6]. Our group has also 
recently demonstrated the independent prognostic value of 
quantitative stress perfusion CMR [11]. 
The fully automated compensation of respiratory motion is a 
key milestone in the process of the clinical translation of the 
quantitative analysis as the inter-frame misalignment caused by 
this respiratory motion can hamper the accuracy of the analysis. 
In particular, voxel-wise quantification of perfusion is desirable 
in order to take advantage of the high spatial resolution of MRI 
and to enable the accurate detection of sub-endocardial 
perfusion defects [12]. Such an approach assumes that a voxel 
represents the same anatomical location in each frame of the 
image series - i.e. that there is no inter-frame misalignment. 
When voxel-wise quantification is used, even misalignments as 
small as one voxel can result in significant errors in the 
quantitative values. 
Current clinical protocols involve acquiring dynamic image 
series which last 50-90 seconds [13]. Breath-holds can only 
effectively prevent respiratory motion during a limited time 
frame of 15-25 seconds, usually during the first-pass of the 
bolus of contrast agent across the left ventricle (LV) cavity and 
the LV myocardium. Hence, even when breath-holds are 
performed, it frequently leads to poor image quality due to the 
residual motion [14]. This can be worsened by incorrect timing 
of the breath-hold, resulting in it not coinciding with the 
passage of the contrast agent in the LV cavity and by the fact 
that patients with coronary artery disease often struggle to hold 
their breath properly, especially under the effects of the 
vasodilator drug. 
More recently, some authors [10], [15], [16] have proposed 
to acquire perfusion images in free-breathing and to apply 
retrospective motion compensation. This approach has the 
advantage of being more tolerable for patients and, with good 
motion compensation, to enable automatically generating 
accurate voxel-wise perfusion maps without requiring manual 
segmentation and manual correction of the position of the heart. 
Furthermore, acquisitions in free-breathing (FB) are more 
robust when compared to breath-hold (BH) acquisitions when a 
motion compensation algorithm is used. Shallow free-breathing 
encourages smooth in-plane motion that aides motion 
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compensation, whereas breath-holds can lead to deep 
inspiration/expiration and sudden motion both in-plane and 
through-plane. Additionally, breath-hold scans can also be 
difficult to retrospectively correct due to the changes in the 
volumes of the ventricles associated with deep inspiration and 
expiration [17]. 
II. BACKGROUND 
The problem of motion compensation can be formulated as 
an image registration problem. The difficulty in the application 
of image registration to the motion compensation of myocardial 
perfusion images is due to the rapidly changing signal 
intensities caused by the arrival and wash-out of the contrast 
agent in the region of interest. In the case of non-rigid 
registrations with vastly different signal intensity profiles, it 
cannot be guaranteed to not introduce unnatural anatomical 
deformations [18], [19]. The cost functions that are optimised 
in the image registrations are global measures [20], they assume 
that the mapping between tissue and image intensity is constant. 
This underlying assumption is violated by the local intensity 
changes. As a result, the cost functions cannot distinguish 
between the intensity variations that are due to spatial motion 
artefacts and those that are due to the contrast enhancement. For 
example, when trying to register a frame with contrast 
enhancement only in the right ventricle to a frame with contrast 
enhancement only in the left ventricle, the algorithm will likely 
try to match the left ventricle to the right ventricle. One possible 
solution to this problem is to only register successive frames in 
the image series so that the contrast enhancement should be 
relatively similar. However, this has the effect of propagating 
the errors from each registration to every subsequent 
registration. Also, particularly during the passage of contrast 
agent from the right ventricle to the left ventricle, the intensity 
change is fast relative to the temporal sampling rate of the 
image series, leading to vastly differing contrast between 
successive frames and the potential for failed registrations. 
A. State-of-the-art 
Several methods to compensate for motion in myocardial 
perfusion MRI data already exist. Adluru et al. [21], [22] 
proposed the use of tracer-kinetic models to create synthetic 
reference images. However, this work only considered rigid 
registration with breath-hold acquisitions and the more general 
applicability of the method is unclear. In particular, the model-
fitting is likely to be difficult with free-breathing acquisitions. 
The method of Melbourne et al. [23] proposed to progressively 
remove motion in the sequence using principal component 
analysis (PCA). The original sequence can hence be motion 
compensated by progressively registering to a motionless 
synthetic image series reconstructed from only early PCs. This 
is equivalent to an iterative spatio-temporal denoising.  
However, this theory breaks down if the acquisition is free-
breathing or there is large amounts of motion, such as a deep 
inspiration, present. This is because the non-random effects of 
the structured motion biases the PCA decomposition. This 
results in the motion manifesting itself in the early PCs. Hence, 
registration to the synthetic PCA-based reference image cannot 
remove the motion. Wollny et al. [15], [24] built on the work of 
Milles et al. [25] and proposed to use independent component 
analysis (ICA) to separate the motion from the image series to 
create synthetic reference images. However, differentiating 
between the independent components and hence removing the 
motion is difficult.  
More recently, Benovoy et al. and Xue et al. proposed 
methods, based on optical flow, that are now components of 
larger software packages for automated quantitative perfusion 
analysis [16], [26]. These methods however do not explicitly 
account for the locally-varying contrast enhancement. As 
demonstrated in Fig. 1, there can be vastly differing contrast 
profiles between frames. Lingala et al. [27] proposed 
deformation corrected compressed sensing (DC-CS) which 
embeds the motion compensation within an iterative 
reconstruction scheme.  The algorithm iterates a reconstruction 
step with registration to a spatio-temporal denoised reference. 
However, it is not clear if it is always possible to create a 
denoised version with no motion but the same contrast profile 
as the original image series in this way. The technique also 
requires many iterations of these steps, the main limitations of 
doing so are the unwanted smoothing of the images caused by 
iterative registrations and the time complexity of such an 
approach. This work will be compared extensively to the 
method proposed in this paper. The review paper of Pontre et 
al. [28] compared many of the aforementioned techniques but 
no clear conclusion was reached. 
B. Our Contribution 
In this study, we propose a robust fully-automated, image-
based approach to the motion compensation of free-breathing 
perfusion MRI image series using a matrix decomposition 
technique, robust principal component analysis (RPCA) [29] 
and non-rigid image registration. This approach is based on the 
observation that RPCA allows the separation of the dynamic 
contrast enhancement from the baseline signal in a myocardial 
perfusion CMR images series. Hence, the deformation fields 
required to eradicate the respiratory motion can be computed in 
the absence of the locally-varying contrast enhancement and 
then applied to the original image series to render it motionless. 
Hamy et al. [30] demonstrated that RPCA allowed motion 
compensation of data from liver, small bowel and prostate 
DCE-MRI. In this work, it is shown that RPCA also facilitates 
the motion compensation of myocardial perfusion MRI data.  
This extension is non-trivial due to the fact the images do not 
just have one enhancing tissue but rather the enhancing tissue 
is surrounded by the two more intensely enhancing blood pools. 
Furthermore, the use of a group-wise registration scheme 
negates the difficulty of choosing a reference frame. The 
motion compensation is conducted in a two-stage approach, the 
first stage uses RPCA, as described above, to account for the 
bulk motion and the second stage is a refinement stage in which 
the image series is registered to a separate motionless synthetic 
image series created using PCA [23] (analogous to the spatio- 
temporal denoising used in DC-CS). The idea is that such a 
denoising will be much more efficient after the first bulk motion 
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compensation step. The validation is conducted with its clinical 
applicability in mind, which is achieved through an assessment 
of the accuracy of myocardial blood flow quantification and by 
the scoring of expert readers. 
III. THEORY 
A. RPCA 
RPCA is a generalisation of traditional principal component 
analysis which, as its name suggests, attempts to make the 
algorithm more robust to corrupt data points [29]. It takes 
advantage of the fact that, in many applications, the data (𝑀) 
can be modelled as a combination of a low-rank component 
(𝐿0) and a sparse component (𝑆0) such that: 𝑀 = 𝐿0 + 𝑆0. 
Mathematically this can be formulated as the solution of: 
 
argmin𝐿,𝑆 ||𝐿||∗ + 𝜆 ||𝑆||1  s. t.   𝐿 + 𝑆 = 𝑀            (1) 
 
where || ∙ ||∗ is the nuclear norm and is defined as the sum of 
the singular values of the matrix. 𝜆 > 0 is a trade-off parameter 
that balances the constraint on the rank of 𝐿 and the sparsity of 
𝑆. Large values of 𝜆 lead to 𝐿 having higher rank and 𝑆 being 
more sparse (𝜆 → ∞ gives 𝐿 = 𝑀 and 𝑆 = 0) and conversely 
smaller values of 𝜆 lead to 𝐿 having lower rank and 𝑆 being less 
sparse (𝜆 → 0 gives 𝐿 = 0 and 𝑆 = 𝑀). The solution of (1) can 
be obtained through an augmented Lagrangian multiplier 
method using an alternating directions approach [31].  
B. Motion Compensation 
Motion compensation was conducted in two stages, this 
scheme followed from the observation that it is difficult to 
optimise the parameters of the image registration algorithms to 
correct for both large and small deformations simultaneously. 
In stage 1, it is attempted to correct for the bulk motion caused 
by the respiration and stage 2 is a refinement step which 
attempts to account for any remaining fine misalignments. The 
analysis is performed on image series that have been cropped 
around the region of interest [32], which vastly reduces the time 
taken for all processing steps. The full scheme is illustrated in 
Fig. 2. 
  
C. Stage 1: bulk motion compensation 
As was shown by Hamy et al. [30], when RPCA is applied to 
a DCE-MRI image series the low-rank component 𝐿 well 
models the baseline signal and the sparse component 𝑆 captures 
the contrast enhancement. This decomposition is shown for two 
example frames in Fig. 3, with videos provided in the 
supplementary material. With a suitable choice of  𝜆, typically 
taken to be 𝜆 = 1/√𝑁𝑝  where 𝑁𝑝 is the number of pixels in an 
image [29], it is therefore possible to obtain a low-rank image 
series 𝐿 which has  a similar motion profile as the original image 
series but without dynamic contrast enhancement. Traditional 
image registration techniques can be easily applied to this low-
rank series as the contrast is similar in each frame. Thereafter, 
the deformation fields which are computed from 𝐿 can then be 
applied to the original image series to eliminate motion.  
 
 
Bulk motion is corrected for using a rigid registration scheme 
which optimises the mutual information cost function [33].   
The registration is applied in a group-wise manner, where all 
frames are registered to the mean frame in an iterative 
framework, with the mean frame being updated on each 
iteration (for a total of 3 iterations). This approach performs 
well as it uses all information at each stage of the registration 
as opposed to considering only two frames at a time. It also 
avoids the uncertainties and errors caused by either developing 
an algorithm to choose a reference frame or doing so in a 
random manner. The iterative refinement of the reference frame 
also avoids the complication of registering two frames which 
 
Fig. 1.  Two pairs of successive frames from a myocardial perfusion MRI 
image series. The first pair ( (a) and (b) ) are during the arrival of contrast 
agent in the right ventricle and the second pair ( (c) and (d) ) are during the 
arrival of contrast agent in the left ventricle. This serves to show that the 
contrast profile is not necessary similar between two successive frames.  
 
 
Fig. 2.  A flow chart of the proposed motion compensation scheme. 
  
 
Fig. 3.  The RPCA based separation of the example images from the original 
image series (M) into its low-rank (L) and sparse components (S). As 
discussed, the local signal enhancement is represented in S with no 
dynamically changing contrast present in L.  
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are far apart; this could lead to unwanted deformations of the 
anatomy. 
D. Stage 2: refinement 
After this first bulk motion compensation, it is observed that 
the remaining motion appears to be jittery and noise-like. 
Hence, in the second stage, the frames are registered to a 
synthetic image series which is created using a PCA 
decomposition to remove the noise-like motion, as was first 
proposed by Melbourne et al. [23]. Fig. 4 shows an example 
frame expressed as a linear combination of the three principal 
eigen-images, a video of such an example series is provided in 
the supplementary material. Each frame from the image series 
resulting from stage one is hence registered to the 
corresponding frame from the motionless PCA-based synthetic 
image series. The motion profile for this synthetic image series 
is shown in Fig. 5. The registrations are performed using free-
form deformations [34] which optimises the residual 
complexity cost function [35] and is performed using a 
Gaussian image pyramid scheme [36]. This step refines the 
original motion compensation, and as such is performed on a 
fine grid of control points (grid spacing (ℎ) of 4 pixels) with 
relatively weak regularisation (𝜅 = 5). These parameters are 
similar to the optimal combination for this application found by 
Wollny et al. [20] (ℎ = 5, 𝜅 = 15). As compared to these 
values, this method uses a finer grid as it is only being used in 
the second stage and thus only correcting fine misalignments. 
This work also uses less regularisation as after the first stage the 
images are already close to being aligned and thus required less 
protection against local optima. All processing steps were 
implemented in Matlab (The MathWorks, Natick, MA, USA) 






A. Study population and image acquisition  
Dynamic perfusion series were prospectively acquired in 
patients referred for cardiac MRI at the School of Biomedical 
Engineering and Imaging Sciences, King’s College London. 
Image acquisition was carried out at 3.0T (Philips Achieva-TX, 
Philips Medical Systems) using standard acquisition protocols 
[13]. Datasets were acquired either in free-breathing or during 
breath-holds. There was 16 free-breathing rest acquisitions, 2 
free-breathing stress acquisitions and 5 breath-hold stress 
acquisitions in total. Images were acquired in 3 short axis views 
using a turbo field echo gradient echo pulse sequence (typical 
acquisition parameters TR/TE/flip angle/saturation prepulse 
delay were 2.5 ms/1.25 ms/15° /100 ms) with a typical spatial 
resolution of 1.34 x 1.34 x 10 mm. The acquisition of the 
images was synchronised to the cardiac cycle using a vector 
electrocardiogram trace. The dynamic image series were 
acquired during first-pass injection of 0.075 mmol/kg 
Gadobutrol (Gadovist, Schering, Germany) at 4 ml/s followed 
by a 20 ml saline flush. A dual bolus contrast agent scheme was 
used to correct for signal saturation of the AIF, as previously 
described [38]. All patients consented to the CMR scan and to 
the inclusion in the study (ethics approval number 15/NS/0030). 
The study was conducted in accordance with the Declaration of 
Helsinki. 
Image series acquired during a breath-hold can contain 
significant and sudden motion, whereas images acquired in 
free-breathing contain a smooth, almost periodic breathing 
pattern [15] due to the encouraged shallow breathing. The 
motion profile is visualised for an example free-breathing 
image series in Fig. 6 which shows the vertical (Fig. 6 (a)) and 
horizontal (Fig. 6 (b)) motion. 
 
 
B. Evaluation  
The method was evaluated in both a qualitative and 
quantitative manner. All metrics were computed for 48 
individual free-breathing rest image series (16 subjects with 3 
slices each), 15 breath-hold stress image series and 6 free-
breathing stress image series. All subjects were free from 
ischaemia and scar. Although quantification of myocardial 
perfusion is routinely done in research settings, it is likely that 
 
Fig. 4. An example image from the image series which can be expressed as a 






Fig. 5. The motion profile of the synthetic reference. This is constructed by 
taking the centre column (a) and row (b) from each image in the series and 
stacking them left to right (a) and top to bottom (b). (a) shows the vertical 
motion (anterior to inferior) and (b) shows the horizontal motion (septal to 




Fig. 6. The motion profile of a free-breathing image series that was created for 
the same image series as shown in Fig. 5. The motion is represented as the 
oscillating pattern and is quite severe in this case. As expected, there is strong 
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visual assessment will remain a part of clinical protocol for the 
near future. With this in mind, the qualitative facet of the 
evaluation involved the grading by expert observers. This 
qualitative assessment compares the original image series to the 
equivalent image series compensated with both the proposed 
framework and the DC-CS method [27].  The quantitative 
assessment involved assessing the temporal smoothness of 
time-intensity curves while also focusing on the spatial 
smoothness of the clinically relevant myocardial perfusion 
values. In the absence of motion, the time-intensity curves 
should be smooth and the quantitative perfusion maps should 
be relatively uniform. The quantitative assessment again 
compares the original image series with the two equivalent 
motion corrected image series.  This follows the recent 
validation paper of Jansen et al. [39]. 
The quality of the motion compensation was assessed by two 
expert observers, blinded to the motion compensation status of 
the image series, with level III CMR accreditation according to 
the guidelines of the Society for Cardiovascular Magnetic 
Resonance (SCMR). The observers (AC and ADMV) viewed 
the image series and graded each of them on a five point scale. 
1=Poor Quality; unnatural deformations, 2=Mediocre Quality; 
significant motion, 3=Acceptable Quality; some motion, 
4=Good Quality; only some unimportant motion, 5=Excellent 
Quality;  no visible motion. The grades from the two observers 
were deemed to be in agreement if they differed by less than 
two, otherwise, a consensus grade was reached. The average 
score from the two observers was then used for assessment.  
In the absence of motion, the only change in voxel-intensity 
is the contrast enhancement. These changes should be smooth 
and slowly-varying. This assumption is violated in the presence 
of motion as voxels can represent different anatomical features 
in consecutive frames. To analyse this temporal smoothness, 
the standard deviation (SD) of the second derivative of the 
voxel-wise time-intensity curves was computed and the mean 
value of this was recorded for each slice. Time-intensity curves 
were smoothed using a Gaussian filter with 𝜎 = 1 (time frame) 
in order to reduce the effect of noise. This smoothing was 
performed in all cases to ensure fair comparison. Only the part 
of the curve relating to the first-pass of the contrast agent is 
assessed. 
Myocardial perfusion is quantified through the relationship: 
𝐶𝑚𝑦𝑜(𝑡) =  𝑅𝐹(𝑡) ∗ 𝐶𝐴𝐼𝐹(𝑡) where 𝑅𝐹, the residue function, is 
constrained by the Fermi function [5], [6]:     
         𝑅𝐹(𝑡) = 𝐹 ∙ [
1
1+exp[(𝑡−𝜏0−𝜏𝑑)∙𝑘]
] ∙ 𝜃(𝑡 − 𝜏𝑑)                (2)    
𝐶𝐴𝐼𝐹(𝑡) is the arterial input function and 𝐶𝑚𝑦𝑜(𝑡) is the 
concentration of contrast agent in the tissue. An estimate of 
myocardial blood flow 𝐹 can hence be obtained by 
deconvolving the observed tissue curve with the AIF.  
The fitting is done with a Levenberg-Marquardt nonlinear 
least square fitting algorithm. 𝜃(𝑡) is the unit step function. The 
algorithm fits for the variables 𝐹, 𝑘 and 𝜏0 and uses a pre-
defined 𝜏𝑑. The fitted value of 𝐹 is taken as the estimate of 
myocardial blood flow, whereas 𝑘 and 𝜏0 define the shape of 
the residue function. Signal-intensity curves are converted to 
concentration of gadolinium by assuming a linear relationship 
(this can be assumed due to the dual-bolus acquisition) [40]. 
Since the image series were acquired from healthy patients, 
relatively uniform perfusion would be expected through-out the 
myocardium as there is no stress-induced ischaemia and no 
scarred tissue, based on the late gadolinium enhancement 
images. However, this will not be the case in the free-breathing 
acquisitions due to motion artefacts in the time intensity curves, 
demonstrated in Fig. 7. Image series were therefore quantified 
with a previously validated in-house software [41], with the aim 
of showing that it is possible to obtain more homogenous 
perfusion maps after motion compensation. In order to make 
this assessment, the SD of each perfusion map was recorded. 
 
V. RESULTS 
A. Qualitative Assessment 
The expert observers scored the 69 image series with three 
different motion compensation statuses (no motion 
compensation, the DC-CS method and the RPCA-based method 
proposed in this work), leading to 207 individual scores. The 
two expert observers assigned identical scores to the image 
series in 63% of the cases. A difference of more than one point 
was only observed in 4/207 cases and in all of these cases a 
consensus score was agreed on. This corresponds to an inter-
observer Spearman’s rank correlation coefficient of 0.80.  
The mean grades (SD) after averaging the grades from each 
observer for the rest image series were 2.1 (0.3), 3.71 (0.64), 
and 4.10 (0.62) for the original free-breathing image series, the 
DC-CS corrected image series, and the RPCA corrected image 
series. The equivalent scores for the stress image series were 
2.76 (0.53), 3.19 (0.66) and 3.57 (0.66). The Wilcoxon signed 
rank test showed that there is a significant (Bonferroni-
corrected) difference between all pairs of populations except 
the stress DC-CS and stress RPCA corrected images (p=0.07). 
Although in this case the trend suggests that the RPCA 
correction works better. This shows that not only does motion 
compensation improve the image quality of free-breathing 
image series, but also that our proposed two-step approach 
gives better results than the previously published  method [27]. 
There are no cases in which the non-motion compensated image 
series scored higher than an equivalent motion compensated 
image series. There was a positive difference in the score 
between the RPCA and DC-CS methods in 48% of the image 
series with a mean improvement of 0.39. Both observers 
confirmed that they would be satisfied to report on the free-
breathing image series in 100% of the cases. Before and after 
 
Fig. 7. Voxel-wise time-intensity curves which were extracted from the 
myocardial segmentation, before and after motion compensation. On the left 
the motion causes the segmentation of the myocardium to be contaminated by 
the left ventricle during the upslope of myocardial signal. After motion 
compensation (right) this effect is corrected and the curves look as expected.  
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motion compensation videos are provided in the supplementary 
materials.  
B. Quantitative Assessment 
In order to assess the temporal smoothness of the time-
intensity curves, the second derivatives of the voxel-wise time-
intensity curves are examined. The SD of this is then computed 
for each curve and the mean value is computed over all curves 
from an individual slice. The median (interquartile range) 
values were 0.28 (0.14), 0.16 (0.06) and 0.13 (0.06) at rest and 
0.14 (0.14), 0.11 (0.09), and 0.09 (0.08) at stress for the non-
motion compensated, DC-CS, and RPCA data respectively. 
Lower values indicate that the change in intensity between two 
successive images in the series is smooth and hence indicates a 
likely reduction in the amount of motion. Fig. 8 shows the 
distribution of these values. The Wilcoxon signed rank test 
shows that the values for the RPCA-based method differ 
significantly from the DC-CS method both at rest (p = 0.013) 
and at stress (p = 0.024). The two motion compensation 
schemes are significantly better than no motion compensation 
both at rest and at stress.  
 The mean (SD) quantitative perfusion values for the original 
image series the DC-CS corrected image series, and the RPCA 
corrected image series are  0.93 (0.33), 0.94(0.40), and 
0.83 (0.26) 𝑚𝑙 ∙ 𝑚𝑖𝑛−1 ∙ 𝑔−1 at rest and 4.02 (0.91), 4.15 
(0.84), and 3.21 (0.73) 𝑚𝑙 ∙ 𝑚𝑖𝑛−1 ∙ 𝑔−1 at stress respectively. 
As expected the means are very similar and in line with what 
we would expect to see [42], the reduction in perfusion after 
motion compensation is due to the lack of artefacts in the 
intensity curves. However, what is more telling is that at rest 
the SD accounts for 73%, 53% and 43% of the mean 
respectively. Due to motion artefacts both the non-motion 
compensated free-breathing have a higher SD than the motion 
compensated image series. The median values of the SD of 
quantitative perfusion value in each slice for the original, DC-
CS corrected and RPCA corrected image series are 0.16, 0.13, 
and 0.14 at rest and 0.61, 0.69 and 0.45 at stress, respectively. 
The distribution of these values is visualised, in Fig. 9.  
 
   
 The Wilcoxon signed rank test shows that the values for the 
image series do not differ significantly to those of the two 
motion compensation schemes, though the trend is clearly 
visible. The homogeneity of the perfusion maps is improved 
particularly with the RPCA based method. Furthermore, the 
homogeneity of the maps at stress for the RPCA corrected 
image series is significantly improved over the DC-CS 
corrected image series for both the free-breathing (p=0.001) and 
breath-hold (p=0.009) image series. 
 
VI. DISCUSSION 
In this study, we introduced a novel method for robust and 
fully-automated, image-based motion compensation of free-
breathing perfusion CMR image series. This method was 
validated both qualitatively and quantitatively. The quality of 
the motion compensation of both rest and stress free-breathing 
and stress breath-hold image series was graded by two expert 
observers in comparison with a previously established method. 
The quantitative assessment compared free-breathing image 
series that had subsequently been motion compensated to the 
original image series and also image series acquired with a 
breath-hold before and after motion compensation. This 
evaluation focused on the clinically relevant quantitative 
perfusion values. The results show an improvement in all 
metrics for the free-breathing image series that have been 
motion compensated using the proposed method as compared 
to the  original image series (30% reduction in the coefficient 
of variation across quantitative perfusion maps, 55% reduction 
in temporal variations (p<0.001)). The uniformity of the motion 
compensated free-breathing stress maps is comparable with the 
breath-hold stress maps. It follows that it may be possible to 
omit the breath-hold from the clinical protocol, making the 
procedure easier for both the patient and the scan operator, 
encouraging smoother respiratory motion which is easier to 
correct and reducing the potential for large gasps and through-
plane motion. 
A. Qualitative Assessment 
There was a reasonable agreement between observers, with 
both observers consistently scoring the image series that had 
been corrected with the RPCA-based method higher than those 
corrected with DC-CS and those with no motion compensation. 
Fig. 10 shows the tMIP of each of the three slices for one patient 
(stress free-breathing) for the three different motion 
compensation statuses, the increased sharpness of the image 
 
Fig. 8. The values for the mean standard deviation of the 2nd derivative of 
myocardial time-intensity curves. This indicates the temporal smoothness of 
the image series. The smoother the transition between successive images in 





Fig. 9. The values for the standard deviation of perfusion values in each map. 
Lower standard deviations indicate more homogenous perfusion maps and 
hence less motion. 
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series corrected with and the RPCA based approach (column 3) 
indicates that there is little residual motion remaining.  
 
 
B. Quantitative Assessment 
The temporal variations of the free-breathing (both rest and 
stress) image series were significantly reduced (by 55%) 
compared to that of the original image series. This indicates that 
the motion compensation is indeed enforcing smooth changes 
between successive images in the series which in turn indicates 
the eradication of motion. The temporal smoothness of an 
example free-breathing image series is visualised through its 
motion profile in Fig. 11. This is the equivalent image series to 
Fig. 6. In Fig. 12, the deep inspiration and expiration caused by 
the breath-hold are obvious. After the breath-hold, large 
amounts of motion can occur due to the subject being out of 
breath and gasping for air. However, in general, this motion in 
the BH image series does not significantly affect the clinically 
relevant quantitative perfusion values. The Fermi 
deconvolution only uses the part of the time intensity curves 
that relate to the first-pass of the contrast agent and this is when 
the breath-hold takes place. However, the BH image series can 
still produce less uniform perfusion maps in the case of 
mistiming or failure of the breath-hold. 
This leads naturally to a comparison of the quantitative 
perfusion values obtained in each case. As previously 
remarked, due to the patients’ status there will be no stress-
induced ischaemia and therefore relatively uniform perfusion 
would be expected throughout the myocardium. In the presence 
of motion this will not be the case due to the motion artefacts in 
the time intensity curves, which impacts the deconvolution. As 
such, the mean standard deviation of the quantitative maps is 
lower after motion compensation with a reduced variability. 
This effect is more pronounced under stressed conditions. 
Breath-hold acquisitions are not robust, mistakes by the 
operator, failed breath-holds by the patient or differences in 
cardiac output between individuals can adversely impact on the 
synchronisation of the acquisition. Hence, there can still be 
significant motion and mistiming during the first-pass of the 
contrast across the left ventricle and the left ventricular 
myocardium in the BH image series. At stress, the quantitative 
maps computed with the motion corrected FB image series are 






A further consideration that contributes to the improved 
uniformity of the motion corrected perfusion maps as compared 
to the BH perfusion maps is the through-plane motion. The 
“gasp” or period of deep breathing following a breath-hold can 
cause significant through-plane motion and cannot be 
retrospectively compensated for using 2D registrations.  
The reported results improve on those obtained with 
previously established methods [27]. Further to the improved 
results, the proposed method is beneficial as it is faster (3.5 
minutes versus 12 minutes on average). From the point of view 
of timing, it is potentially advantageous that the motion 
compensation is achieved in two steps rather than in the many 
iterations of an iterative procedure.  
The bulk compensation step can also deal with structured 
motion (such as periodic motion and large inspiration) better 
 
Fig. 10. The temporal maximum intensity projection of the three slices from a 
free-breathing stress acquisition. The increase in sharpness in the RPCA 
corrected series indicates a lack of motion. The blurring artefacts as a result of 




Fig. 11. The equivalent motion profile for the same image series as shown in 
Fig. 6 after motion compensation. The smooth transition between frames 





Fig. 12. The equivalent motion profile as shown in Fig. 6 for a breath-hold 
acquisition. In this image series there is a period of free-breathing followed by 
a breath-hold during the passage of the main bolus and then another period of 
free-breathing. The breath-hold is short relative to the passage of the contrast 
agent, this will impact the tissue curves from the myocardium and 
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than the iterative denoising. When compared to directly using 
the PCA-based approach [23], this approach is deemed to be 
more applicable to myocardial perfusion imaging. This is 
because the bulk motion compensation step removes the non-
random effects in the data which then allows the successful 
application of PCA. This leads to better results with both free-
breathing and breath-hold data (the clinical standard). Videos 
which demonstrate the effect of the non-random motion in free-
breathing acquisitions on the PCA-based approach are provided 
in the supplementary material.  
The benefits of the proposed approach are that there is no 
assumptions made on the acquisition system and parameters or 
even the imaging modality. The resulting motion compensated 
image series were of higher visual quality. The quantitative 
information was shown to be preserved after motion 
compensation, with more robust estimate of myocardial blood 
flow due to reduced motion artefacts in the signal intensity 
curves.   
C. Limitations 
There is a lack of a ground-truth to validate this method. We 
have attempted to account for this by conducting the evaluation 
in a multitude of different manners. 
To date, the method has only been validated with one set of 
acquisition parameters. Although we believe there is no reason 
the acquisition parameters should influence this method, it 
would be desirable to demonstrate this on further datasets.  
Despite the fact this is a 2D compensation for the 3D motion 
of the heart, image series acquired in the short-axis view with 
shallow breathing will have predominantly in-plane motion. In 
our datasets, it is not possible to correct through-plane motion 
in due to the large slice thickness, large distance between slices 
and the limited sampling of the left ventricular myocardium.  
VII. CONCLUSION 
We have demonstrated the feasibility of a robust fully-
automated, image-based approach to the motion compensation 
of free-breathing perfusion CMR images using the matrix 
decomposition technique, robust principal component analysis 
(RPCA) and non-rigid image registration and shown its efficacy 
using clinical data. With the use of motion compensation 
algorithms, the evidence presented in this study suggests that a 
breath-hold protocol for the acquisition of first-pass myocardial 
perfusion MRI data may be no longer necessary. Motion 
compensated free-breathing acquisitions led to significantly 
more uniform quantitative perfusion maps than the original 
images. The variation of motion corrected free-breathing 
perfusion maps is equivalent to breath-hold clinical 
acquisitions. Our method performs well in comparison with the 
established methods in the literature. Additionally, both expert 
observers noted that the motion compensated free-breathing 
image series were all of satisfactory quality for visual 
assessment. In summary, in addition to the increased 
convenience of free-breathing acquisition, our motion 
compensation scheme produces image series of high visual 
quality and allows the robust quantification of myocardial 
perfusion.    
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Chapter 5
Deep learning-based preprocessing for
quantitative myocardial perfusion MRI
5.1 Preface
The field of image processing was revolutionised when a deep convolutional neural network,
AlexNet [91], won the ImageNet Large Scale Visual Recognition Challenge by a large margin
in 2012 [92]. This was the first demonstration that modern computer hardware, such as graphics
processing units (GPUs), could be combined with large databases to train deep neural networks
to successfully perform computer vision tasks.
Since this, deep learning has been widely adopted in the field of medical imaging and has
become the de facto standard for many processing tasks [93]. Trends in cardiac MRI image
analysis have followed a similar route where deep learning is now used for everything from
reconstruction to detection and segmentation tasks to automating diagnostics and prognostics
[94].
The main advantage of deep learning is that the networks learn the features to be used to
complete the task from the data rather than these being hand-engineered. Such hand-crafted
features are biased by preconceived ideas of the programmer and thus tend to be brittle. An
example of this, in the context of perfusion CMR, is the problem of bounding box detection
which is a common first step in processing pipelines. Before the advent of deep learning, a
popular approach for this task was based on thresholding temporal variances. The logic behind
this was that the contrast flowing causes the areas of highest temporal variance to be the RV and
LV cavity. However, this approach was shown to fail in 4/44 case [95] and we found similarly
high rates of failure in our implementation. An example of this algorithm with some of the
common failure modes is shown in Figure 5.1. For this reason, deep learning is used in this
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work for the image processing required to turn the raw image series into concentration curves
for tracer-kinetic modelling.
Fig. 5.1 The top row shows the temporal standard deviation image, the thresholded standard
deviations, and the result of the connected component analysis to identify the RV and LV (from
left to right). The bottom row shows two failed cases. On the left, there only one component (a
joint LV and RV) is identified and on the right four similar components are identified.
5.1.1 Supervised deep learning for image processing
Supervised learning
Supervised learning attempts to learn a model that takes input data and outputs labels [96].
That is, to learn the function f which depends on parameters θ that best maps the input space
X to the output space Y:
fθ : X→ Y. (5.1)
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A training set of matched data and labels is required to find the best set of model parameters
to map the input data to labels. The trained models can subsequently be applied to unseen test
data to obtain a prediction of its label. This is opposed to unsupervised learning which attempts
to learn structure in the data [96].
Deep learning
Deep learning is the sub-field of machine learning based primarily on the use of neural networks
[96]. Artificial neural networks are functions made up of layers of units or neurons. Each unit in
a layer takes, as input, the output of the units in the previous layer. It then computes a weighted
combination of these inputs and applies a non-linear activation function. The weights needed
for the weighted combination are the parameters of the neural network and are optimised in
order to solve the task at hand. The typical neural networks composes many internal layers and
are thus described as deep. A simple neural network, with two hidden layers (layers in addition
to the input and output layers), is illustrated in Figure 5.2 As previously discussed, the early
layers can be thought of as extracting features from the input data, while the later layers learn
to combine these features to meet the objective. This yields a model function in the form:
fθ (x) = f LθL( f
L−1
θL−1
(· · · f 0θ0(x) · · ·)) (5.2)
where f i
θi
is the ith layer with parameters θi.




A network where all units are connected to all units in the previous layer is said to be fully-
connected. This design is inefficient or infeasible for image processing because of the high
dimensionality of the inputs (the dimensionality is equal to the number of pixels or voxels in the
image). An alternative network design, more suitable for image processing, is the convolutional
neural network (CNN), as visualised in Figure 5.3. A CNN combines inputs from only a small
region of the previous layer (commonly referred to as the receptive field and designed to loosely
resemble the visual cortex). This is implemented as a learnable kernel being convolved with
the output of the previous layer to generate the input for the current layer. The convolutional
kernel is designed to be significantly smaller than the size of the activation it is being convolved
with. This enforces sparse interactions between layers and allows the extraction of low level
features, such as edges, without considering the whole image. Parameter sharing is also used
such that the same kernel is applied to all inputs to a layer. This aids the training process by
greatly reducing the number of parameters to be learned. CNNs also encourage translational
invariance in the predictions. Since a kernel slides over the whole input it will detect the same
features regardless of their position. This is useful, for example in classification tasks, when it
only matters if an object is in an image and not where it is [96].
Fig. 5.3 A convolutional neural network. This shows the layers of the CNN downsampling the
input image and producing a 3D volume of activation (left), and a unit connected to a small
receptive field in the previous layer (right), image taken from https://cs231n.github.io/
U-Net
The most commonly used network architecture for medical image processing is the U-Net
[97]. This is a fully-convolutional network in that it only uses convolutional layers, and is
illustrated in Figure 5.4. The architecture has an encoder-decoder structure. The encoder
downsamples the input image, using max-pooling, to create a low-dimensional embedding.
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The multi-step downsampling allows the learning of feature representations at different image
scales. The decoder, takes the low-dimensional embedding and upsamples it to try predict the
desired output, typically a segmentation map. The network also utilises skip connections that
concatenate the activations of the encoder to the corresponding resolution level of the decoder.
This is thought to better allow the recovery of the fine-grained details in the prediction.
Fig. 5.4 The U-Net model architecture, image adapted from https://www.nist.gov/.
Training neural networks
Neural networks can be trained (the optimal parameters estimated) using first-order stochastic
optimisation algorithms to minimise a loss function L between the estimated network output ŷ
and the training labels y. The most simple approach to this is stochastic gradient descent:
θ ← θ −α∇θL (y, ŷ) (5.3)
where α is the learning rate that controls the size of the parameter updates made in the
optimisation. The algorithm is referred to as stochastic as it does not consider the whole dataset
at each iteration, for computational efficiency. Parameter updates are instead made using the
gradients computed on a small sub-sample of the training data, known as a mini-batch. Due
to the layer-wise nature of neural networks, as seen in Equation 5.2, the gradient of the loss
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with respect to the parameters of a layer can be computed using the chain rule, in a process is
known as backpropagation.
A more advanced (and recently more popular) gradient descent update rule is the ADAM
optimiser [98] which uses adaptive learning rates and momentum to achieve better convergence
properties [96].
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Background: Quantitative myocardial perfusion cardiac MRI can provide a fast and robust assessment of myocardial perfusion
status for the noninvasive diagnosis of myocardial ischemia while being more objective than visual assessment. However, it cur-
rently has limited use in clinical practice due to the challenging postprocessing required, particularly the segmentation.
Purpose: To evaluate the efficacy of an automated deep learning (DL) pipeline for image processing prior to quantitative
analysis.
Study Type: Retrospective.
Population: In all, 175 (350 MRI scans; 1050 image series) clinical patients under both rest and stress conditions (135/10/30
training/validation/test).
Field Strength/Sequence: 3.0T/2D multislice saturation recovery T1-weighted gradient echo sequence.
Assessment: Accuracy was assessed, as compared to the manual operator, through the mean square error of the distance
between landmarks and the Dice similarity coefficient of the segmentation and bounding box detection. Quantitative per-
fusion maps obtained using the automated DL-based processing were compared to the results obtained with the manually
processed images.
Statistical Tests: Bland–Altman plots and intraclass correlation coefficient (ICC) were used to assess the myocardial blood
flow (MBF) obtained using the automated DL pipeline, as compared to values obtained by a manual operator.
Results: The mean (SD) error in the detection of the time of peak signal enhancement in the left ventricle was 1.49 (1.4)
timeframes. The mean (SD) Dice similarity coefficients for the bounding box and myocardial segmentation were 0.93 (0.03)
and 0.80 (0.06), respectively. The mean (SD) error in the RV insertion point was 2.8 (1.8) mm. The Bland–Altman plots
showed a bias of 2.6% of the mean MBF between the automated and manually processed MBF values on a per-myocardial
segment basis. The ICC was 0.89, 95% confidence interval = [0.87, 0.90].
Data Conclusion: We showed high accuracy, compared to manual processing, for the DL-based processing of myocardial
perfusion data leading to quantitative values that are similar to those achieved with manual processing.
Level of Evidence: 3
Technical Efficacy Stage: 1
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FIRST-PASS MYOCARDIAL PERFUSION IMAGINGwith cardiac magnetic resonance imaging (MRI) has been
shown to be highly accurate for the detection of coronary artery
disease (CAD)1,2 and suitable for guiding the management of
patients with an intermediate risk of CAD.3,4 Visual interpreta-
tion of the images, however, is complex, time-consuming, and
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the accuracy of the results is dependent on the level of training
and experience of the operator, thereby limiting the adoption of
these techniques outside highly experienced centers.5
An alternative to the visual assessment is quantitative
perfusion analysis, which is made possible by the use of tracer-
kinetic modeling.6 Quantitative perfusion analysis can be
automated7,8 leading to fast, robust, and reproducible estimates
of myocardial perfusion.9 Quantitative analysis has been
validated against positron emission tomography (PET),10–12
fractional flow reserve,13 and microspheres.14,15 Sammut et al
have also recently demonstrated the independent prognostic
value of quantitative stress perfusion MRI in patients with
suspected CAD.16 The availability of automated and standard-
ized methods for quantitative analysis could facilitate the wider
adoption of first-pass myocardial perfusion imaging.
The quantitative analysis requires challenging image
processing.17 It is required to identify the left ventricular
blood pool to extract an arterial input function (AIF) to use
along with the myocardial tissue curves in the model fitting.
The segmentation of the myocardium is also desirable, as it
allows the analysis of values specifically in the region of inter-
est (ROI) and the computation of the myocardial perfusion
reserve (MPR), which is the ratio of perfusion values at stress
to the values at rest. The use of a segmentation also requires
fewer voxels to be fit to the model, which is more time-
efficient and allows the use of more advanced fitting algo-
rithms that take advantage of spatial information.18,19 Further
advanced analysis techniques involve the assessment of the
transmural gradient in contrast uptake across the myocar-
dium20 or the assessment of the temporal dyssynchrony of
first-pass perfusion,21 for which an ROI is necessary. The
identification of the right ventricular (RV) insertion points
would also be beneficial in order to divide the myocardial seg-
mentation into the standard American Heart Association
(AHA) segments22 and to relate perfusion abnormalities to
coronary territories.
Myocardial perfusion image series present unique chal-
lenges to automated segmentation approaches due to the
dynamic contrast-enhancement and the relatively low signal-
to-noise ratio (SNR). We propose that the automation of
these processing steps can be achieved by leveraging the
power of machine learning. In particular, deep learning has
produced impressive results in many computer vision tasks
such as image detection and recognition. Recently, deep
learning has also seen more attention in the field of medical
image analysis23 and specifically in cardiac MR image analysis
with fully convolutional neural networks (FCNs) being
applied to the segmentation of anatomical structures in a vari-
ety of different applications.24,25
In this work, we developed deep-learning models in
order to achieve the requisite preprocessing steps prior to
quantitative modeling. These steps were tested individually
and as part of the fully-automated pipeline.
Materials and Methods
Subjects
The dataset consisted of 175 subjects (64.3  10.3 years old;
136 male) with suspected CAD referred on a clinical basis to King’s
College London Cardiac MR Service at St Thomas’ Hospital (Guy’s
and St Thomas’ NHS Trust). The dataset was randomly split into
three sets of 135/10/30 for training/validation/testing. The full
demographic and clinical characteristics of the patients is reported in
the Supplementary Material, Table S1. The study was conducted in
accordance with the Declaration of Helsinki (2000) and was
approved by the National Research Ethics Service (15/NS/0030). All
patients provided written informed consent.
Imaging
All examinations were performed with a 3T system (Achieva TX,
Philips Healthcare, Best, The Netherlands) using a 32-channel car-
diac phased array receiver coil. Perfusion images were acquired in
three left ventricle (LV) short-axis slices (apical, mid-cavity, and
basal) at mid-expiration with a saturation-recovery gradient echo
method (repetition time / echo time 3.0/1.0 msec, flip angle 15,
saturation-recovery delay 120 msec, 5-fold k-t sensitivity encoding
[k-t SENSE] acceleration with 11 training profiles, giving a net
acceleration of 3.8-fold, spatial resolution 1.2 × 1.2 × 10 mm3).
Stress images were acquired during adenosine-induced hyperemia
(140 μg/kg/min); 0.075 mmol/kg of bodyweight gadolinium (Gd)
extracellular contrast agent (gadobutrol, Gadovist, Bayer, Germany)
was injected at 4 mL/s followed by a 20-mL saline flush for each
perfusion acquisition. Each bolus of gadobutrol was preceded by a
diluted prebolus with 10% of the dose to allow quantification of
perfusion, according to published methods.26
Processing Pipeline
As shown in Fig. 1, the first step of the pipeline is to detect the
timeframe from the image series that corresponds to peak signal
enhancement in the LV. Using this image, a bounding box is
detected that encompasses the LV cavity and LV myocardium. The
cropped image series are then passed to the motion correction
scheme that we have described in detail in previous work.27 The
next step involves segmenting the motion-corrected and cropped
peak LV contrast-enhancement timeframe to generate a myocardial
mask and then the RV insertion points are detected. The AIF is
extracted from a region identified using a region-growing algorithm
starting from the position of highest signal inside the endocardial
boundary, as defined by the automated segmentation. The AIF along
with the voxelwise concentration curves extracted from the myocar-
dium are then used for perfusion quantification using tracer-kinetic
modeling. The RV insertion points are used to relate the quantitative
perfusion values to AHA 16-segment model. The full pipeline pro-
posed in this section is summarized in Fig. 1.
Each constituent component of the pipeline was evaluated
using a suitable metric. Furthermore, the quantitative perfusion
values achieved with the fully automated pipeline were then com-
pared to those achieved using the manual analysis from an expert
operator. This allows the assessment of the effectiveness of the whole
pipeline and demonstrates the feasibility of its unsupervised deploy-
ment in the clinic.
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Training Labels
The epicardial and endocardial borders were manually traced at the
time of peak LV enhancement using cvi42 software (Circle Cardio-
vascular Imaging, Calgary, Alberta, Canada) by an experienced oper-
ator (E.S., level 3 competency accreditation,28 with more than
5 years of experience in cardiac MRI). The RV insertion points were
subsequently marked. The timepoint was found by scrolling
through the timeframes in the viewer until a satisfactory frame was
reached and this timepoint was used for training the LV peak
enhancement classifier. The training labels for the bounding box
were obtained from the segmentation by computing the smallest
box that fits the entire myocardium and expanding it by 20 voxels
in each dimension. This analysis was repeated by a second experi-
enced operator (A.V., level 3 accredited28 with more than 5 years
of experience in cardiac MRI) for the test set to assess the inter-
observer variability rate.
Training Details
Each of the 175 patients in the dataset underwent perfusion imaging
under both rest and stress conditions in which three LV short-axis
slices were acquired yielding a total of 1050 (three imaging planes at
both rest and stress for each patient) individual image series. The
networks were trained individually for each of the four steps. Prior
to training, the images were interpolated to the required dimension,
as described in the individual sections, using bicubic interpolation.
All images were normalized to have intensity values in the range of
[0,1]. On-the-fly data augmentation was applied to the training
images, which consists of applying random amounts of translation,
rotation, scaling, intensity variation, and noise to the images. A
batch size of 32 was used in the training of all networks. L2
regularization on the parameters of the convolution kernels was used
with a weight of 0.001. The respective cost functions were optimized
using the Adam optimizer29 with a learning rate of 0.0001 until con-
vergence. Early stopping with a patience of 3000 iterations, assessed
using the validation accuracy, was used to determine convergence.
Peak LV Enhancement Detection
A convolutional neural network (CNN) was used to identify the
timeframe corresponding to peak contrast-enhancement in the
LV. The CNN takes each timeframe in the image series (256 × 256
voxels) along with the two preceding and two subsequent timeframes
as input and outputs as a single number that represents the probabil-
ity that that timeframe corresponds to the peak LV enhancement in
the series. The CNN consists of four convolutional layers followed
by two fully-connected layers and is similar to those previously
shown to be successful for image recognition tasks.30 Each con-
volutional layer uses 3 × 3 kernels and is followed by a 2 × 2 max-
pooling layer. It uses batch normalization and rectified linear unit
(ReLU) activations except for the output layer, which uses a
softmax activation, as shown in the Supplementary Material,
Table S2. Dropout is used with probability 0.5 in the fully-
connected layers. The model was trained by minimizing the cross-
entropy loss function.
In order to identify the time of peak LV enhancement in a
new image series, the trained classifier was applied individually to
each timeframe in the image series. This approach gives a probability
for each timeframe to be the peak LV enhancement image. The
timeframe with the highest probability is taken as the estimate. A
plot of the probability over time for an image series is shown in the
Supplementary Material, Fig. S1.
FIGURE 1: The flow chart representing the pipeline for automated myocardial perfusion quantification. The peak LV enhancement
frame in the image series is first identified. This timeframe is then cropped (motion correction is then applied), the myocardium
segmented, and RV insertion point determined. Perfusion is quantified using tracer-kinetic modeling in the myocardium and this is
combined with the RV insertion point to generate the bullseye plot.
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Bounding Box Detection
The architecture used to detect the bounding box is the same as that
used in the previous step except that the output is now four continu-
ous values rather than the class probabilities (a linear activation is
used for the four output units). The network takes the frame of peak
LV enhancement as input (256 × 256 voxels) and outputs the
parameters that define the bounding box. It is, however, known to
be challenging to train a network to directly detect the coordinates
of the corners of the bounding box.31 A solution to this problem
was inspired by the idea of region proposals used by the Faster
R-CNN architecture.32 That is, it first assumes that the object,
which in this case is the LV cavity and LV myocardium, is within a
75 × 75 voxel ROI centered around the center of the image. The
CNN then outputs how much to adjust this ROI so that it better
fits the area of interest. The output of the CNN is the displacement
of the center of the proposed ROI and scaling factors for the width
and height of the proposed ROI. An example image is shown in
Fig. 2, with the original proposed ROI and the identified deforma-
tion. The mean squared error between the computed transformation
of the proposed ROI and the true transformation required was opti-
mized. The CNN was trained using only the peak LV enhancement
timeframe from the basal slice and during testing is only applied to
the basal slice. Due to the shape of the LV and the planning of the
short axis, the bounding box computed on the basal LV slice also
applies to the mid-ventricular and apical slices.
Myocardial Segmentation
The myocardial segmentation utilizes the U-Net architecture,33
which is a fully convolutional network. The input to the network is
an image of size 96 × 96 voxels (the cropped and motion-corrected
peak LV enhancement frame) and the output is an image of the
same size which corresponds to the voxelwise classifications of the
myocardium. The architecture is summarized in the Supplementary
Material, Table S3. The cost function that was optimized was the
Dice similarity coefficient (DSC)34 between the detected segmenta-
tion and the human operator segmentation.
The final segmentation is taken as the largest connected compo-
nent of the binary mask. Failed segmentations are detected automati-
cally by assessing whether the segmentation achieves the expected
"closed-loop" shape of the myocardium. In the case of a failed segmen-
tation, a correction is attempted in a similar manner to Fahmy et al.25
As previously described, the nearby timeframes have very similar appear-
ances. Therefore, in the case of a failed segmentation, the segmentation
network is applied to all images within two timeframes of the detected
peak LV enhancement. The segmentation from the closest timeframe
that achieves the expected shape is taken as the segmentation.
Insertion Point Detection
The problem of detecting landmarks in medical images is known to
be challenging.35 This is due to the high noise levels, large variation
in the location of the landmark across subjects, and differences due
to subjective positioning of the landmarks by different operators.
This makes it extremely difficult to train a regression model to out-
put the coordinates of the landmark. An image-to-image approach
such as U-Net can be used to output a segmentation that contains
just the one voxel of the landmark location. However, such an
approach suffers from the class imbalance problem.
Our approach builds on the idea of supervised action classifiers,
as proposed by Xu et al.31 For each case, an action map is created that
represents for each voxel in the image the direction (left, right, up, or
down) towards the landmark. An example activation map is shown in
Fig. 3 (right). An FCN was then trained to detect which one of these
four partitions each voxel belongs to. The U-Net architecture is used
here and is the same as was used for the myocardial segmentation
except for the output activation, which is a softmax rather than a
sigmoid to reflect the fact that this is now a multiclass classification
problem. The cross-entropy loss function was optimized. From the
computed activation maps, regression lines were fit to the boundaries
of the partitions and the estimate of the RV insertion point was taken
as the intersection of these lines, as shown in Fig. 3 (left).
Evaluation
Each step of the pipeline was evaluated individually by computing a
relevant metric for each patient in the test set. For the peak LV
enhancement frame detection, the mean difference (in number of
timeframes) between the visually chosen timeframe and the detected
timeframe was used to evaluate the performance. For both the
bounding box detection and the myocardial segmentation steps, the
DSC between the outputs and those that were manually acquired is
reported. For the segmentation, the metric is compared to the inter-
observer variability rate found from repeated segmentations by differ-
ent operators. For the RV insertion points, the Euclidean distances in
terms of mm was used to measure the performance.
Perfusion Quantification
Quantitative perfusion analysis was performed on the test cases using
both the manually obtained labels and the deep-learning outputs.
The perfusion quantification used a two-compartment exchange
model6 for which the kinetic parameters were inferred using
FIGURE 2: The original proposed ROI (dotted line yellow
bounding box) for an example patient. The arrows indicate the
deformation output by the CNN to give the ROI for this patient
with the detected bounding box shown as the blue continuous
line bounding box.
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hierarchical Bayesian inference, as previously described.19 Bland–
Altman analysis was used to analyze the bias and limits of agreement
between the manual and automated analysis and the linear relation-
ship and intraclass correlation (ICC) between the obtained quantita-
tive values was assessed.
Results
Representative example cases, with a comparison between man-
ual and automated processing, are shown in Supplemental
Figs. S3–S7.
Peak LV Enhancement Detection
The accuracy of the classifier when applied individually to
images in the test set was 97.6%. When the peak LV
enhancement frame was chosen, as described in the
Methods section, the mean (standard deviation [SD]) dif-
ference in terms of timeframes (n = 60, 30 patients rest
and stress) was 1.48 (1.4). The maximum error was three
timeframes. It can be noted that even in this case the
detected timeframe is very similar to the manual choice
and is a reasonable choice for the peak LV enhancement
frame, shown in Supplementary Material Fig. S2.
Bounding Box Detection
The mean (SD) DSC between the detected and manually
selected bounding box for the test set (n = 60, 30 patients rest
and stress) was 0.93 (0.03).
Myocardial Segmentation
The mean (SD) DSC between the automated and manual
segmentations (n = 180, 30 patients with three imaging slices
rest and stress) was 0.80 (0.06). The lowest DSC recorded on
the test set was 0.69; this image with its corresponding man-
ual and automated segmentation is shown in Fig. S5d. The
segmentation of 5 out of 180 test images failed and they were
replaced with a successful segmentation computed using a
nearby timeframe. The mean (SD) DSC between the seg-
mentations of observer 1 and observer 2 was 0.83 (0.05).
Some example images from the different observers are shown
in Supplementary Material Fig. S8.
RV Insertion Point Detection
The mean (SD) Euclidean distance (in mm) between the auto-
mated and manually chosen RV insertion points (n = 360,
180 imaging slices × 2 insertion points) was 2.8 (1.8).
FIGURE 3: Left: the RV insertion point marked on an example
patient with the lines of slope  1 that separate the regions of
the action map overlaid. Right: The resulting action map, with
the direction towards the landmark point shown for each pixel.
FIGURE 4: Left: Bland–Altman plots of the automatically processed vs. manually processed quantitative perfusion values averaged
over each of the 16 AHA segments. Blue and orange lines represent the bias and  1.96 SD limits, respectively, with the shaded
regions being the 95% confidence intervals. Right: A scatterplot of the manually processed vs. the automatically processed
quantitative perfusion values averaged over each segment of the myocardium. The plotted line is the computed line of best fit with
no intercept (slope = 0.93).
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Perfusion Quantification
The automatically and manually processed test image series
resulted in a mean (SD) myocardial blood flow (MBF) of
0.93 (0.37) and 0.91 (0.39) mL/min/mL at rest (n = 90) and
2.04 (0.89) and 2.09 (1.26) under stress (n = 90), respec-
tively. These values are in line with the ranges previously
reported in the literature.7,8,36 The use of the RV insertion
points further allows the division of the myocardium from
the three acquisition slices into the AHA 16-segment model.
The Bland–Altman analysis showed a good agreement
between the automated and manual MBF values on a per-
segment basis (n = 960, 30 patients with rest and stress × 16
AHA segments) (Fig. 4, left) with the bias being 2.6% of the
mean MBF value. There was a strong correlation between the
MBF values automatically and manually processed with a
slope (with no intercept) on a per-segment basis of 0.93 with
an R2 of 0.76 (Fig. 4, right). The ICC was 0.89, 95% confi-
dence interval [0.87, 0.90].
Discussion
In this work we introduced an automated, deep-learning-
based preprocessing pipeline for the quantification of myocar-
dial perfusion MRI. The deep learning pipeline processes an
image series in a few seconds, compared to roughly 5 minutes
for a manual operator, allowing the full quantitative analysis
to be performed automatically in just a few minutes. Each
step of the pipeline was validated independently, with good
results reported. The accuracy of the segmentation was com-
parable to the interobserver agreement and the quantitative
analysis performed with the fully automated pipeline
yielded MBF values that were in line with those computed
with the manual interaction at each step. The fully auto-
mated pipeline was also successful in each image series
(180/180) in our test set, indicating the robustness of this
approach. As demonstrated by the similarity of the quanti-
tative perfusion values obtained with both the automated
and manual pipelines, the pipeline is not sensitive to the
errors seen in detecting the peak LV enhancement frame,
bounding box, and RV insertion points or segmenting the
myocardium.
Despite the increased challenges posed by first-pass perfu-
sion images, the average (SD) DSC reported is in a similar
range to that reported for the segmentation in a comparable
automated pipeline for T1 mapping (0.80 [0.06] vs. 0.85
[0.07]).25 It is also similar to the performance of the model Bai
et al24 developed when applied to a clinical dataset including
diseased patients.
There has been previous work reporting fully-
automated solutions for myocardial perfusion quantifica-
tion.7,8 However, neither of these solutions at present
provide a myocardial segmentation, which is the most
time-consuming manual task for the operator. The benefits
of automatically segmenting the myocardium include
reduced processing time in the quantification step, more
interpretable parameter maps, and direct statistics for the
ROI. The use of a myocardial segmentation has the poten-
tial to give a more objective diagnosis; for example, it
allows the computation of the extent of perfusion defect as
a percentage, which is a strong indicator of future events.
Furthermore, fitting the model parameters in only the
myocardium allows the use of spatial regularization18,19
and the computation of the differences in perfusion
between the endocardial and epicardial layers of the myo-
cardium and perfusion dyssynchrony measures.20,21
A possible alternative pipeline could have involved the
individual segmentation of each timeframe in the image
series. In theory, this approach would not require an explicit
motion correction step, as the segmentations for each time-
frame could be matched to each other. It is the success of
our recently validated motion correction scheme27 that
allows us to process just one timeframe. The benefits of this
approach include that it is not necessary to design a scheme
for matching points in different segmentations across differ-
ent timeframes to extract voxelwise concentration curves.
Moreover, it was significantly easier to gather high-quality
training data, as an observer was only asked to segment the
single frame at peak LV enhancement from each slice,
reducing the manual work by a factor of 100. This is likely
to be important for groups that want to reproduce the pipe-
line. It is also a significant consideration when acquiring
more data to use transfer learning to adapt the pipeline to
different acquisition parameters in the future. Our approach
is also likely to be more robust, as we have chosen only the
timeframe with the highest SNR and contrast to process.
The segmentation of all timeframes would also include
precontrast frames where there is very little signal in the
myocardium to guide the segmentation.
A further strength of this work is that it used a repre-
sentative clinical dataset for training, including a significant
proportion of diseased patients, so by default should be
applicable in the clinic on data acquired using similar
methods. Transfer learning techniques have already been
shown to be able to account for differences in the input
domain and we envisage a future application to extend the
pipeline to data acquired from different types of scanners at
different centers.24,25
In our study, the size of the dataset available was lim-
ited. In order to negate this problem, data augmentation was
employed. Online data augmentation was used with random
transformations added to the data before each iteration of
training. This helps the network to generalize better and to
learn a more robust representation of the myocardium. How-
ever, this only addresses the lack of training data; it would be
beneficial to further test the method on a larger dataset. A
further limitation is that the primary endpoint of the analysis,
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the quantitative perfusion values, does not have a ground-
truth available for validation and that we have only shown
that the quantitative values that are similar to those achieved
manually by an expert operator. This does not investigate the
diagnostic accuracy of these quantitative values, and thus fur-
ther work to establish the diagnostic accuracy of the auto-
mated pipeline is warranted.
In conclusion, we proposed a fast and automated
method for processing myocardial perfusion MR images prior
to quantitative analysis. This automates the time-consuming
and subjective processing tasks, such as myocardial segmenta-
tion, and performs on a par with the manual experts. We
anticipate that this will lead to increased adoption of quanti-
tative perfusion analysis in the clinic as well as opening up
new possibilities for research in the field.
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5.3 Supplementary material
N = 175
Male gender 136 (78%)




Current / previous smoker 24 (14%) / 18 (10%)
CAD status (visual assessment) -
- 1 vessel 43 (25%)
- 2 vessels 28 (16%)
- 3 vessels 31 (18%)
Table 5.1 Demographic characteristics of the population.
Layer Input size Convolutional kernel Number of filters
1 256 x 256 3 x 3 8
2 128 x 128 3 x 3 16
3 64 x 64 3 x 3 32
4 32 x 32 3 x 3 64
FC 1 8192 - -
FC 2 512 - -
Table 5.2 The architecture used for the peak LV enhancement frame detection and bounding
box detection. FC 1 and FC 2 are the fully connected layers. Each convolutional layer involves
convolutional with the filter with a stride length of 2 followed by batch normalisation and ReLU
activation. Max-pooling is performed after every convolutional layer.
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Layer Input size Convolutional kernel Number of filters
1-3 96 x 96 3 x 3 16
4-6 48 x 48 3 x 3 32
6-9 24 x 24 3 x 3 64
9-12 12 x 12 3 x 3 128
12-15 6 x 6 3 x 3 256
15-18 12 x 12 3 x 3 128
18-21 24 x 24 3 x 3 64
21-24 48 x 48 3 x 3 32
24-27 96 x 96 3 x 3 16
Table 5.3 The U-Net architecture used for the myocardial segmentation and the RV insertion
point detection. On the downward trajectory (layers 1-12) each layer involves convolutional
with the filter with a stride length of 2 followed by batch normalisation and ReLU activation.
Max-pooling is performed after every third convolutional layer to down-sample the image
dimensions. On the upward trajectory (layers 16-27), each layer still involves convolutional
with the filter with a stride length of 2 followed by batch normalisation and ReLU activation
with transposed convolutions being performed before every third layer to up-sample the image
dimensions. Features are concatenated across the layers of the same scale, as previously
described.
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Fig. 5.5 The probability of being the peak LV enhancement frame over time. An increased
probability is seen as contrast arrives in the LV, reaching a peak with the peak signal frame
(marked with an X) and then reducing as the contrast washes out. The network also assigns
relatively high probabilities to the time frames corresponding to the pre-bolus injection.
Fig. 5.6 A comparison of the automated and manually chosen peak LV enhancement time
frame for the patient with the largest error (3 beats) in the test set. The 2 frames are virtually
indistinguishable on visual assessment.
5.3 Supplementary material 59
Fig. 5.7 A comparison of the automated and manually chosen peak LV enhancement time frame
from a representative set of patients from the test set. The error is in terms of the number of
time frames.
Fig. 5.8 A representative set of patients from the test set with a comparison between the
automatically and manually determined bounding boxes.
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Fig. 5.9 A representative set of patients from the test set with a comparison between the
automated segmentation and the manually defined segmentations.
Fig. 5.10 A representative set of patients from the test set with a comparison between the
automatically detected RV insertion point and the manually defined RV insertion point (error is
in mm).
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Fig. 5.11 A representative patient from the test set with a comparison between the automatically
processed quantitative perfusion maps and the manually processed quantitative perfusion maps.
Coronary angiography showed the patient has CAD with a lesion in the proximal left circumflex
coronary artery.
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As discussed in Section 3.3.2, the quantification of myocardial perfusion is an inverse problem.
Given an observed AIF and myocardial tissue curve, the problem is to find the kinetic parameters
such that the model best matches the observed data.
The question of whether or not the parameters are recoverable from the data is known as
identifiablity. Romain et al. [100] showed that tracer-kinetic models of the form considered
in this thesis are structurally identifiable. This is a strictly theoretical proof that states that
the parameters are exactly recoverable in ideal, noise-free, infinite temporal resolution case
because the mapping from the parameters to the residue function is a bijection.
The more pressing concern for the use of such models in real-world settings is the practical
identifiablity. Practical identifiablity assesses the feasibility of recovering the correct parameters
given the limited, imperfect measurements available. This has long been called into question
for myocardial perfusion modelling and DCE-MRI in general. In 2002, Buckley [6] reported on
the vast amount of possible parameter combinations that are indistinguishable at the noise level
present in the data: "the issue of parameter uniqueness is further complicated by the surfeit
of possible parameter combinations" and remarked that this introduces significant uncertainty
in the estimates. This uncertainty has been similarly noted by an array of other authors
[101–103] and specific to myocardial perfusion CMR, Likhite et al. [55] reported the same
phenomenon: "A shortcoming with complex pharmacokinetic models is that identical tissue
curves can be generated using a single arterial input function and multiple sets of perfusion
model parameters".
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However, it is of course possible to get the correct parameters, as is evidenced by the many
successful studies conducted in the field [37, 80, 32, 81, 33]. It is a question of the trade-off
between the amount of information in the data and the complexity of the model to be estimated.
For example, the amount of information in the data can be increased by fitting the model on an
AHA segment level rather than a pixel-wise level [37, 81]. On the other hand, the complexity
of the model can be reduced by considering models with less parameters, for example, the
Fermi model [32].
A relatively unexplored approach to increasing the amount of information available in the
data is through the use of prior knowledge. This approach is investigated in this thesis, in a
Bayesian inference framework.
6.1.1 Bayesian kinetic parameter estimation.
If we define Cθ (t) = Fp ·R(t;θ) ∗CAIF(t) to be the output of the tracer-kinetic model for a
given set of parameters θ , T to be the total number of time points, and y = (y1,y2, . . . ,yT ) to be
the observed myocardial concentrations at times t = (t1, t2, . . . , tT ), then the standard non-linear









It can be seen that argminx x = argmaxx exp(−x) and since constant scaling factors do not












N (Cθ (t),σ2). (6.3)
where N (µ,σ2) is the Gaussian distribution with mean µ and variance σ2. The term being
maximised is known as the likelihood function, and is also written as P(y|θ), this can be
interpreted as the likelihood of observing the data that was observed, conditioned on the
parameters. It is therefore seen that the NLLS solution is the maximum likelihood parameter





As previously discussed, the least squares solution can possess local optima and the global
minima can be hard to find. This is a limitation as the method returns a single point estimate
that must be assumed to be the true value. An alternative approach, Bayesian inference, is
to assume that there is a distribution of possible parameter values and to try to compute this
distribution. Bayes theorem allows the posterior distribution of the parameters to be written in
terms of the likelihood function as:
P(θ |y) = P(y|θ) ·P(θ)
P(y)
(6.5)
where P(θ) is the prior probability of the data and p(y) =
∫
θ
P(y|θ) ·P(θ)dθ is the probability
of the data. From the posterior distribution, the expected value of the parameters can be
computed and also the standard deviation of the distribution gives a measure of the uncertainty
of the parameter estimates. The difficultly is that the posterior distribution is not, in general,
analytically tractable as it involves integrals which can not be computed and thus, numerical
solutions must be considered.
6.1.2 Metropolis-Hastings
The Metropolis-Hastings algorithm is commonly used to numerically approximate posterior
distributions. There are some definitions required to introduce the Metropolis-Hastings al-
gorithm: a Markov chain is a random process, with discrete time steps, that has the Markov
property. The Markov property states that the conditional probability of a future state of the
random process depends only on the current state and not on any of the past states. The limiting
distribution of a Markov chain is the distribution that it converges to asymptotically. Finally, a
Monte Carlo method is simply a method that uses random samples to solve a problem.
Then, the Metropolis-Hastings algorithm is a Markov chain Monte Carlo (MCMC) method
to approximate a distribution by simulating samples from it. It aims to construct a Markov
chain with limiting distribution that is the distribution being approximated. It does this by
taking a random walk through the distribution space, where the steps are proposed by a proposal
distribution. If the posterior probability of the proposed position is greater than the posterior
probability of the current position, the proposed step is accepted. If not, the proposed step
can also be accepted with a probability proportional to the reduction in posterior probability it
would cause. With the notation that samples θ are being sampled using a proposal distribution
q from the target distribution π(·), the Metropolis-Hastings algorithm is given by Algorithm 2.
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Algorithm 2: Metropolis-Hastings
Initialise :θ 0
1 for iteration i = 1,2, . . . ,N do
2 θ cand ∼ q(θ i|θ i−1);
3 α = min{1, q(θ i−1|θ cand)π(θ cand))q(θ cand |θ i−1)π(θ i−1) };
4 u∼ Uniform[0,1];
5 if u < α then
6 θ i← θ cand;
7 else
8 θ i← θ i−1;
9 end
10 end
Output : (θ 0,θ 1, . . . ,θ N)
It is common to use a symmetric proposal distribution such that q(a|b) = q(b|a) such that:
q(θ i−1|θ cand)π(θ cand))




It should also be noted that π is only required up to a constant scaling factor (as this would
cancel in the numerator and denominator) so when approximating the posterior distribution for
parameter inference, it is sufficient to use P(y|θ) ·P(θ) as:
P(θ |y) ∝ P(y|θ) ·P(θ). (6.7)
Metropolis-Hastings is the approach used for the parameter inference in this thesis. However,
there are more efficient sampling approaches being developed, such as Hamiltonian Monte
Carlo sampling [104], which use gradient information to inform proposals, rather than random
walks. This encourages movement towards areas of high probability and thus more efficient
samples.
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Myocardial perfusion MRI 
a b s t r a c t 
Myocardial blood flow can be quantified from dynamic contrast-enhanced magnetic resonance (MR) 
images through the fitting of tracer-kinetic models to the observed imaging data. The use of multi- 
compartment exchange models is desirable as they are physiologically motivated and resolve directly for 
both blood flow and microvascular function. However, the parameter estimates obtained with such mod- 
els can be unreliable. This is due to the complexity of the models relative to the observed data which is 
limited by the low signal-to-noise ratio, the temporal resolution, the length of the acquisitions and other 
complex imaging artefacts. 
In this work, a Bayesian inference scheme is proposed which allows the reliable estimation of the param- 
eters of the two-compartment exchange model from myocardial perfusion MR data. The Bayesian scheme 
allows the incorporation of prior knowledge on the physiological ranges of the model parameters and 
facilitates the use of the additional information that neighbouring voxels are likely to have similar kinetic 
parameter values. Hierarchical priors are used to avoid making a priori assumptions on the health of the 
patients. We provide both a theoretical introduction to Bayesian inference for tracer-kinetic modelling 
and specific implementation details for this application. 
This approach is validated in both in silico and in vivo settings. In silico , there was a significant reduction 
in mean-squared error with the ground-truth parameters using Bayesian inference as compared to using 
the standard non-linear least squares fitting. When applied to patient data the Bayesian inference scheme 
returns parameter values that are in-line with those previously reported in the literature, as well as giving 
parameter maps that match the independant clinical diagnosis of those patients. 
© 2019 The Authors. Published by Elsevier B.V. 
This is an open access article under the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 
1. Introduction 
Dynamic contrast-enhanced magnetic resonance imaging (DCE- 
MRI) can be used for the non-invasive assessment of myocardial 
perfusion ( Chiribiri et al., 2009 ; Jaarsma et al., 2012 ; Nagel et al., 
2003 ). According to recent clinical guidelines, it is indicated for 
the assessment of patients at risk of coronary artery disease (CAD) 
( Montalescot et al., 2013 ; Windecker et al., 2014 ) and has been ex- 
tensively validated against the reference standard, fractional flow 
reserve ( Li et al., 2014 ; Nagel et al., 2019 ). Currently, the clini- 
cal evaluation of such images is performed visually. The spatial 
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and temporal distribution of contrast agent in the myocardium can 
identify myocardial ischaemia and provide insight into the pres- 
ence and severity of stenoses. Some of the main limitations of 
this visual assessment are the difficulty of interpreting the im- 
ages ( Villa et al., 2018 ) and the underestimation of the ischaemic 
burden in patients with multivessel CAD ( Patel et al., 2010 ). This 
has led to myocardial perfusion examinations only being routinely 
performed in highly experienced centres. Quantitative perfusion 
analysis has been proposed as a more reproducible and user- 
independant alternative to the visual assessment and has been 
shown to have a good diagnostic accuracy and prognostic value 
( Hsu et al., 2018 ; Knott et al., 2019 ; Sammut et al., 2017 ). 
The quantification of myocardial perfusion from DCE-MRI data 
is achieved by applying tracer-kinetic models to track the pas- 
sage of the contrast agent from the left ventricle (LV) to the my- 
ocardium to allow the inference of the kinetic model parame- 
ters, such as myocardial blood flow (MBF) ( Broadbent et al., 2013 ; 
https://doi.org/10.1016/j.media.2019.101611 
1361-8415/© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 
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Hsu et al., 2018 ; Jerosch-Herold et al., 1998 ; Kellman et al., 2017 ; 
Wilke et al., 1997 ). However, there have been questions raised on 
the reliability of the quantitative parameters values that are es- 
timated from DCE-MRI data due to the complexity of the mod- 
els relative to the observed data ( Buckley, 2002 ). This had led to 
the use of simplified models, such as the Fermi function ( Jerosch- 
Herold et al., 1998 ; Wilke et al., 1997 ) or concentration curves that 
have been averaged over a region of the myocardium in order to 
boost the signal-to-noise ratio (SNR). To this end, a recent edito- 
rial by Axel ( Axel, 2018 ) calls for improved quantitative methods, 
in particular more robust quantitative values in order to allow the 
clinical translation of the technique. 
Larsson et al. ( 1996 ) showed that they could not reliably fit the 
five parameters needed for the tracer-kinetic modelling to the ob- 
served data, using least-squares fitting. As shown in the compara- 
tive study of Schwab et al. ( 2015 ), they were able to achieve reli- 
able quantification with relatively simpler models, such as a Fermi- 
constrained deconvolution, but not with the multi-compartment 
exchange models. Broadbent et al. ( 2013 ) report failed fitting in 
10% of cases (despite using concentration curves that have been av- 
eraged over a segment of the myocardium) and Likhite et al. ( 2017 ) 
also reported failed fittings to simulated data even though this is 
simplistic with respect to the patient data. 
Some of the reasons behind the reported difficulties in the 
model fitting include that such parameter estimation, or non- 
linear regression, problems are known to get stuck in local op- 
tima ( Dikaios et al., 2017 ; Kelm et al., 2009 ). As a result, even 
though the model-based concentration curves may well match the 
observed data, the reported parameters may be far from the true 
values. It has further been shown that the model parameters are 
correlated ( Romain et al., 2017 ) and thus there are multiple dis- 
tinct combinations of parameters that give outputs that are indis- 
tinguishable at the observed noise level. Also, as is typical with 
non-linear optimisations, the parameter estimates are highly sen- 
sitive to the initial conditions of the optimisation and the specific 
noise present in the data. A further limitation is that this non- 
linear least-squares fitting does not explicitly deal with the uncer- 
tainty in the estimated kinetic parameters. 
In conclusion, there is need for an improved methodology to 
allow robust and reproducible estimation of the kinetic model pa- 
rameters including, but not limited to, MBF. In this work, we de- 
velop and evaluate a framework to robustly infer the kinetic model 
parameters from the observed imaging data based on hierarchi- 
cal Bayesian probabilistic modelling. This approach has been suc- 
cessfully employed in many similar applications, such as popula- 
tion dynamics in ecology ( Rosenbaum et al., 2019 ). The proposed 
method is validated using simulation phantoms where gold stan- 
dard kinetic parameters are known and subsequently further test- 
ing on clinical data is reported. 
2. Background 
2.1. Tracer-kinetic models 
The tracer-kinetic models as presented in the literature 
( Ingrisch and Sourbron, 2013 ; Sourbron and Buckley, 2013 ) model 
the perfusion unit (a single voxel or segment) as a system with 
two interacting compartments - the plasma and the intersti- 
tium. These models give a pair of coupled differential equations 
which describe the evolution of the contrast agent as a non- 
linear function of physiological parameters, such as MBF. In this 
work, the tracer-kinetic model analysis was performed by fitting a 
two-compartment exchange model (2CXM) ( Jerosch-herold, 2010 ; 
Sourbron and Buckley, 2013 ) to the observed concentration curves 
v p 
d C p ( t ) 
dt 
= F b 
1 − Hct ( C AIF ( t ) − C p ( t ) ) + P S ( C e ( t ) − C p ( t ) ) (1) 
v e 
d C e ( t ) 
dt 
= P S ( C p ( t ) − C e ( t ) ) . (2) 
In (1) and (2) , C p ( t ) and C e ( t ) are the concentration of contrast 
agent in the plasma and interstitial space at time t , respectively 
(in units of M). C AIF ( t ), the arterial input function (AIF), is the as- 
sumed input to the system that is being modelled (also in units of 
M). In myocardial perfusion quantification this is sampled from the 
LV. F b is the MBF (mL/min/mL), v p is the fractional plasma volume 
(dimensionless), v e is the fractional interstitial volume (dimension- 
less) and PS is the permeability-surface area product (mL/min/mL). 
Hct is the haematocrit value (dimensionless). 
This model has the benefit over other simpler models in that it 
resolves directly for MBF. The simpler models, such as those pre- 
sented by Tofts and Kermode (1991) , only allow the estimation of 
the K trans parameter which can be influenced by either MBF or the 
extraction fraction. The Fermi function ( Jerosch-Herold et al., 1998 ; 
Wilke et al., 1997 ) does resolve for MBF but not other kinetic pa- 
rameters and the model is not physiologically motivated. 
The solution to this system is then given as: 
C ( t ) = R F ( t, ) ∗ C AIF ( t − τ0 ) (3) 
with the analytic form of the residue function R F presented in 
the appendix.  = ( F p , v p , v e , PS ) T and τ 0 is the time delay term 
which accounts for the fact that the contrast agent does not move 
instantaneously from the left ventricle to the myocardial tissue. 
This is an unknown parameter that must also be estimated. The 
concentration that is observed in the MRI experiment is the contri- 
bution from both compartments and is given as: C(t) = v p · C p (t) + 
v e · C e (t) . 
2.2. Non-linear regression 
The standard technique to estimate the model parameters uses 
a least-squares method. Given the observed contrast agent concen- 
trations y = ( y ( t 0 ) , y ( t 1 ) , . . . , y ( t N−1 ) ) T , it is assumed that: y ( t j ) = 
C ( t j ) + ε j where ε j are the error terms and comprise of both 
noise and other sources of error, such as motion. The estimation 
of the parameters is then to find the  which minimises the sum 
of squared errors cost function χ2 : 















Under the assumption that the error terms come from indepen- 
dant and identically distributed Gaussian distribution this is equiv- 
alent to the maximum likelihood estimate as it maximises the like- 
lihood function p ( y | ). 
As previously discussed, this technique can break down in the 
case where the cost function has multiple local minima. That is, 
there are multiple values of  that produce similar model output. 
If this is the case, the values of the parameters estimated may de- 
pend strongly on the initial conditions of the optimisation and be 
far from the true values. Furthermore, in vivo , the time delay pa- 
rameter τ 0 can introduce further local minima. 
An example of such a cost function is shown in Fig. 1 . It is 
seen that when noise is added, two local optima emerge, neither 
of which corresponds to the true parameter values. The optimisa- 
tion will converge to one of these depending on its initial condi- 
tions. In other cases it is possible for the cost functions to possess 
long flat valleys where optimisation may stop due to the update 
being less than the required tolerance leading to unreliable param- 
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Fig. 1. An example of a cost function created using simulated data, on the left in the noise-free case and on the right with a SNR of 15. This image is constructed by taking 
the minimum intensity projection over the three parameters v p , v e and PS to allow the visualisation of the 5-dimensional surface as a function of F b and τ 0 . The true 
parameter values used in the forward simulation are F b = 1 . 0 , v p = 0 . 08 , v e = 0 . 16 , PS = 0 . 4 , τ0 = 0 . 1 . In the noise-free (left) case the cost function has a global minimum 
which corresponds to the true parameter values (yellow dot). In the presence of noise (right) it is seen that there are two local optima, neither of which corresponds to the 
true parameter values. The optimisation will converge to one of these depending on its initial conditions. The yellow circle is the position of the true minimum of the cost 
function and the two cross symbols are the positions of the two local minima. 
Fig. 2. For the same arterial input function AIF (red curves) and the same ground-truth parameters ( F b = 3 . 6 , v p = 0 . 08 , v e = 0 . 16 , PS = 0 . 5 ) the two blue curves are simulated. 
Their only difference being the Rician noise realisation. A comparison of the two fits shows a difference of a factor of two in the computed MBF. This could vastly change 
the patients’ diagnosis. 
eter estimates. This cost function was constructed using simulated 
data and can possess further local optima due to the complex er- 
rors and physiology seen in patient data. Additionally, as shown 
by Sommer and Schmid ( 2014 ), the analytic form of the residue 
function R F , which is the sum of two exponentially decaying com- 
ponents, can lead to an identifiability problem when the two ex- 
ponents are too similar or when the contribution of one compart- 
ment vanishes which can further reduce the reliability of the pa- 
rameter estimates. 
Fig. 2 shows two myocardial tissue curves that have been sim- 
ulated using the same parameters, with the only difference be- 
ing the realisation of the Rician noise that is added. This could 
be interpreted as being two curves from neighbouring voxels with 
the same underlying physiology. In this example it is seen how 
the traditional non-linear regression algorithms can yield vastly 
different fits, with the two fitted MBF values ( F b ) being different 
by a factor of two despite being simulated with the same kinetic 
parameters. 
2.3. Bayesian parameter estimation 
The aforementioned maximum-likelihood approach assumes 
that there is one true value of the parameter and computes a point 
estimate of this. Conversely, Bayesian estimation treats the param- 
eters as random variables and approximates their posterior distri- 
bution. This hence allows computation of the expected value of the 
parameter. The variance of the distribution also allows an expres- 
sion of confidence in the value of the parameter estimate. 
It is assumed that the observed data y ( t j ) at each time point 
t j , j = 0 , . . . , N − 1 comes from the model with some Gaussian er- 
ror with variance σ 2 
j 
such that: y ( t j ) ∼ N ( C ( t j ) , σ 2 j ) . To then 
examine the model parameters given observed data, the posterior 
distribution p ( | y ) is required. The posterior distribution can be 
obtained through the application of Bayes’ theorem 
p ( | y ) = p ( y | ) · p ( ) ∫ 
 p ( y | ) · p ( ) d
∝ p ( y | ) · p ( ) . (5) 
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The term p ( ) is the prior probability of the parameters. It is 
common to assume that the parameters θ i are independant and so 
p ( ) is the product of the prior distributions over the individual 
parameters, θ i . 
In general, the posterior distribution is not analytically tractable 
and must be approximated using Markov chain Monte Carlo 
(MCMC) sampling. Through (5) , it is possible to compute samples 
which are proportional to the posterior distribution and MCMC 
sampling utilises these samples to construct a Markov chain with 
a stationary distribution equal to the posterior distribution. It does 
this using a proposal distribution which is used to propose, ran- 
domly, how to move in parameter space and an acceptance rule 
which is used to decide whether to accept the proposed move or 
not, based on the information from the likelihood and the prior 
information. An introduction to the use of Bayesian modelling for 
non-linear regression problems is given in the book of Seber and 
Wild (1989) . 
2.3.1. Hierarchical Bayesian modelling 
Quantitative myocardial perfusion MRI is a natural application 
for the use of hierarchical Bayesian modelling. In this modelling 
approach, the prior probability distribution is not governed by 
fixed hyperparameters but rather hyperparameters α which are de- 
scribed by a further probability distribution, i.e. a hyperprior p ( α). 
Hence,  in (5) is now dependant on these hyperparameters and 
(5) becomes: 
p ( , α| y ) ∝ p ( y | , α) · p ( | α) · p ( α) . (6) 
This approach is useful when the data is structured into dis- 
tinct but not entirely unrelated groups. This is referred to as par- 
tial pooling, as opposed to complete pooling (use of one fixed prior 
distribution) or no pooling (use of different priors for each group). 
For example, in a stress perfusion MRI, these distinct groups could 
be healthy and diseased tissue. If the same prior knowledge was 
used for both groups, then it would lead to an averaging effect over 
these regions. Hierarchical modelling is thus an attractive compro- 
mise between treating the groups equivalently and having com- 
pletely independant models. 
2.3.2. Generalised Gaussian Markov random field prior 
In addition to prior distributions on the kinetic parameters, it 
is possible to incorporate spatial prior knowledge. This enforces 
smoothness in the spatial domain and it motivated by the idea 
that neighbouring voxels should exhibit similar kinetic properties. 
In particular, in this application, a generalised Gaussian Markov 
random field prior is suitable. Mathematically, this is equivalent to 
putting prior distributions on the differences between parameters 
in neighbouring voxels that have zero mean: 




‖ W ( i −  j ) ‖ p p 
)
, if j ∼ i (7) 
where j ~ i if j and i are neighbouring voxels and 1 ≤ p ≤ 2. Here, 
ν i, j is the rate parameter (inverse of the scale parameter) of the 
distribution and W is the weighting coefficients. The use of p = 1 
corresponds to the Laplace distribution and is known to have edge- 
preserving properties ( Bardsley, 2012 ). 
3. Methods 
3.1. Simulation experiments 
The proposed method was first tested using simulated image 
series as the parameter estimates can be compared to ground-truth 
values. The 6 by 6 voxel image series was created using ground 
truth tracer-kinetic parameter maps with values as expected in 
the myocardium under three different realistic conditions mim- 
icking a healthy patient at rest, a healthy patient at stress and a 
patient with stress-inducible ischaemia ( Broadbent et al., 2013 ). 
The parameter maps were used to forward simulate the model 
with a gamma-variate function used to generate a realistic AIF. 
The kinetic parameter values used in the simulation were F b = 
3 . 5 , v p = 0 . 08 , v e = 0 . 16 , P S = 1 . 0 in healthy voxels at stress and 
F b = 1 . 0 , v p = 0 . 08 , v e = 0 . 16 , P S = 1 . 0 in healthy voxels at rest. 
The simulation phantom mimicking a patient with stress-inducible 
ischaemia was created using F b = 3 . 5 , v p = 0 . 08 , v e = 0 . 16 , P S = 1 . 0 
with two disconnected regions with reduced MBF ( F b = 1 . 0) added 
to mimic regions of stress-inducible myocardial ischaemia. Rician 
noise was added to the image, with the level chosen to achieve 
a realistic SNR of 15 ( Broadbent et al., 2016 ; Cheng et al., 2007 ). 
The SNR here was defined to be the ratio of the standard devia- 
tion of the noise realisation to the maximum of the tissue curves. 
The data curves were simulated with a realistic temporal resolu- 
tion of t = 0 . 012 min, corresponding to a heart rate of roughly 
83 beats per minute at stress and t = 0 . 017 min at rest, for a to- 
tal time T = 3 min. The proposed parameter estimation method is 
compared in a Monte-Carlo study for n = 20 distinct noise reali- 
sations, for each simulation phantom, with a traditional, gradient- 
based optimisation scheme in order to assess the accuracy and the 
reproducibility of the parameter estimates. The normalised mean 
square error (NMSE) between the true and estimated kinetic pa- 
rameters is reported and a Mann-Whitney U test is used to com- 
pare the distribution of the NMSE values from the Monte-Carlo 
study. A further assessment is conducted (also using the NMSE val- 
ues) to compare the proposed hierarchical model to an equivalent 
non-hierarchical approach. 
3.2. In vivo experiments 
The technique was tested in eight patients suspected of having 
CAD referred for stress perfusion cardiac MRI at King’s College Lon- 
don. Image acquisition was performed on a 3.0T scanner (Philips 
Achieva-TX, Philips Medical Systems) using standard acquisition 
protocols ( Kramer et al., 2013 ) . The typical acquisition parameters, 
TR/TE/flip angle/saturation prepulse delay were 2.5 ms/1.25 ms/15 ◦
/100 ms with a typical spatial resolution of 1.34 × 1.34 × 10 mm. 
The dynamic image series were acquired during first-pass injec- 
tion of 0.075 mmol/kg Gadobutrol (Gadovist, Schering, Germany) 
at 4 ml/s followed by a 20 ml saline flush. A dual bolus contrast 
agent scheme was used to correct for signal saturation of the AIF, 
as previously described ( Ishida et al., 2011 ). Images were acquired 
under adenosine-induced stress. The images were acquired with a 
breath-hold during the passage of the main bolus, as is done clin- 
ically, and also retrospectively motion corrected using a previously 
validated scheme ( Scannell et al., 2019 ). 
As aforementioned, a dual-bolus acquisition is performed in or- 
der to mitigate the difficulties caused by the non-linear relation- 
ship between the concentration of contrast agent and the MRI sig- 
nal intensities. It is hence assumed there is a linear relationship 
between the concentration of contrast agent and the signal in- 
tensity. The concentration of gadolinium (C(t)) was approximated 
from the signal intensities (S(t)) using an application specific ver- 
sion of the relative signal enhancement ( Biglands et al., 2015 ; 
Ingrisch and Sourbron, 2013 ): 
C ( t ) = 1 
r 1 · T 1 b 
(
S ( t ) − S ( 0 ) 
S LV ( 0 ) 
)
(8) 
with the T 1 b of blood taken as 1736 ms and r 1 the contrast agent 
as 4.5 s −1 mmol/ L − 1 ( Broadbent et al., 2016 ). S(0) is the average 
of the first five acquired images before the injection of contrast 
agent. Similarly, S LV (0) is the pre-contrast signal in the left ventric- 
ular blood pool. 
In the case of this patient data, there are no ground-truth 
parameter values to compare to. Therefore, the purpose of this 
6.2 Journal article 70
C.M. Scannell, A. Chiribiri and A.D.M. Villa et al. / Medical Image Analysis 60 (2020) 101611 5 
study is to test whether the kinetic parameter values that are es- 
timated can identify perfusion defects that match the independant 
visual assessment found in the clinical reports. This provides in- 
sight into the reliability of the fittings and the ability of the pro- 
posed method to deal with the more complex curves and error 
terms that are present in patient data. The number of failed fittings 
and outlier kinetic parameter estimates are further compared be- 
tween implementations. All scans were reported blindly by expe- 
rienced operators with level III CMR accreditation according to the 
guidelines of the Society for Cardiovascular Magnetic Resonance 
(SCMR). As per the expert assessment, four patients were classified 
as being positive for ischaemia and four were classified as not hav- 
ing obstructive coronary artery disease. In this work, stress scans 
only are considered as rest scans have been shown to not increase 
diagnostic accuracy ( Biglands et al., 2018 ; Villa et al., 2018 ). The 
myocardium was contoured using the cvi 42 software (Circle Car- 
diovascular Imaging Inc., Calgary, Alberta, Canada) by an experi- 
enced operator with level III CMR accreditation (SCMR) and the 
segmentations were exported using the open-source code of Bai 
et al. ( 2018 ). 
3.3. Non-linear regression implementation 
All steps are implemented in Python, using the SciPy mod- 
ule for the optimisation ( Jones et al., 2001 ). The nonlinear re- 
gression approach uses the L-BFGS ( Zhu et al., 1997 ) nonlinear 
optimisation scheme with box constraints. Each parameter was 
constrained to be within conservative physiological limits and 
to conform with what has been previously found with tracer- 
kinetic models ( Broadbent et al., 2013 ). The parameters are con- 
strained such that: 0.001 ≤ F b ≤ 6.0, 0.001 ≤ v p ≤ 0.3, 0.001 ≤ v e ≤ 0.4 
and 0.001 ≤ PS ≤ 4.0. This fitting is repeated several times with dif- 
ferent initial conditions randomly chosen from a uniform distribu- 
tion on each of these ranges. One initialisation and 100 initialisa- 
tions are used for comparison on the simulated data with 100 ini- 
tialisations used on the patient data. The reported parameter es- 
timates are then the successful fit which has achieved the lowest 
cost function value. This is done to reduce the effect of the choice 
of the initial conditions on the parameter estimate and to min- 
imise the risk of converging to local optima ( Dikaios et al., 2017 ; 
Romain et al., 2017 ). A fit is defined as successful if it achieves 
a tolerance of less than 10 −8 within 10 0 0 iterations and none of 
the resulting parameters achieve their upper or lower bounds. The 
AIF ( C AIF ( t )) is extracted using independant component analysis 
( Jacobs et al., 2016 ) and the bolus arrival time is estimated using 
the method of Cheong et al. ( 2003 ). 
3.4. Bayesian parameter estimation implementation 
The Bayesian parameter estimate was implemented using an in- 
house software developed in Python. The posterior distribution for 




i , αi | y i ) ∝ p (y i | i , αi ) · p (i | αi ) · p (αi ) (9) 
It is assumed that the observed data in voxel i at time t j is 
Gaussian distributed, i.e. that y i ( t j ) ∼ N ( C i ( t j ) , σ 2 i ) . This gives 
rise to the likelihood function: 
p 
(
y i | i , αi ) = (2 πσ 2 i )− N 2 exp 
( 
− 1 














In this work, F b (mL/min/mL) is selected to be Gaussian dis- 
tributed with mean αb and a fixed variance 0.2. PS (mL/min/mL) is 
Gaussian distributed with mean αS and variance 0.1. αb is taken to 
be uniformly distributed on [0,7] and αS is taken to be uniformly 
distributed on [0,5]. v p (%/100) is assumed to be uniformly dis- 
tributed on [0,0.4] and v e (%/100) is assumed to be uniformly dis- 
tributed on [0,0.5]. These were chosen to be in line with previously 
reported literature values ( Broadbent et al., 2013 ) and physiological 
intuition. The priors are chosen to be weakly informative in that 
they encompass a much larger range of values than the values that 
have been found previously in the literature. Rather than express- 
ing confidence about the parameters being close to a certain value, 
it acts as regularisation and restricts the parameter estimates to 
these ranges. The prior distribution on the observed error (in M) 
for voxel i ( σ 2 
i 
) is taken to be a flat Inverse-Gamma distribution, 
with shape parameter c = 0 . 001 and scale parameter d = 0 . 001 , as 
is conventional. 
A Laplace prior with location 0 and scale 0.1 is chosen on the 
absolute value of the distance between the kinetic parameter es- 
timates of neighbouring voxels. The Laplace distribution is chosen 




i | αi ) = p (F i b | αi b ) · p (v i p ) · p (v i e ) · p (P S i | αi PS ) · p (σ 2 i )




2 · 0 . 1 
(
F i b − αi b 
)2 ) × I (v i p ∈ ( 0 , 0 . 3 ] )
× I 
(





2 · 0 . 1 
(

















0 . 2 
∑ 





∣∣i k − j k ∣∣)
) 
(11) 
I (X ) is the indicator function on the set X which takes the value 
1 on X and 0 otherwise. n ( i ) is the set of neighbouring voxels of 
voxel i . A voxel’s neighbours are those voxels in its surrounding 4- 
neighbourhood, above, below, to the left and to the right of it. Due 
to the shape of the myocardium, it is possible that a voxels neigh- 
bours are not in the myocardial segmentation. In such a case, a 
voxel diagonally above or below is taken or failing that, the closest 
voxel that is in the myocardium. 
The difference between the parameter estimates in neighbour- 
ing voxels i and j is computed using a weighted sum. The weights, 
W k are used to account for the different scales of the parameters, 
since otherwise, differences in the higher magnitude parameter 
values ( F b and PS ) would have a dominating effect com pared to 
the lower magnitude parameter values ( v p and v e ). The value of 
the weight for a given parameter W k on a given iteration of the 
MCMC sampling is the inverse of the previous sample of the pa- 
rameter. For the non-hierarchical model it is taken that F b ∼ N ( X , 
0.2) and P S ∼ N (1.0, 0.2), where two values of X (3.5 and 1) have 
been used for comparison. 











αi PS ∈ [ 0 . 001 , 5 ] 
)
(12) 
In this work, the Metropolis-Hasting algorithm with random 
walk proposals is used to sample from the posterior distribution. In 
short, the Metropolis-Hasting algorithm moves randomly through 
parameter space using a proposal distribution. The proposal distri- 
bution proposes a move in parameter space that is then accepted 
with a probability that is related to the change in posterior proba- 
bility associated with the new sample. This leads to the construc- 
tion of a Markov chain with a stationary distribution that approxi- 
mates the posterior distribution. 
In the work, the choice of the above distributions and their re- 
spective variances was made, empirically, to optimise the trade-off
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Table 1 
NMSE and Mann-Whitney U test results for the hierarchical Bayesian and non-linear least squares kinetic parameter estimates. The Mann-Whitney U test 
compares the estimates from the Bayesian inference to those achieved with non-linear least squares (100 initialisations). 
Parameter Bayesian Non-linear least squares (1 initialisation) Non-linear least squares (100 initialisations) p-value (Mann-Whitney U test) 
All 0.13 (0.2) 0.72 (0.74) 0.32 (0.55) p < 0.0001 
F b 0.05 (0.09) 0.46 (0.44) 0.1 (0.09) p = 0.002 
v p 0.22 (0.27) 0.27 (0.21) 0.35 (0.31) p = 0.02 
v e 0.12 (0.16) 0.31 (0.19) 0.20 (0.17) p = 0.01 
PS 0.11 (0.21) 1.83 (0.5) 0.63 (0.96) p < 0.0001 
between thoroughly exploring parameter space and sticking to ar- 
eas with high posterior probability. They were chosen in order to 
achieve a rate of acceptance of proposals close to 0.234 which has 
previously been shown to be optimal ( Roberts et al., 1997 ). Markov 
chains of 40 0 0 steps were constructed. In order to assess the sta- 
tionary distribution of the chain, the initial 10 0 0 steps were dis- 
carded, referred to as the burn-in phase. The number of steps was 
chosen to be far in excess of the number needed for convergence 
according to the ˆ R statistic ( Gelman and Rubin, 1992 ). In order to 
create parameter maps, the median value of the posterior distribu- 
tion are reported and to examine the uncertainty associated with 
such a parameter estimate, the coefficient of variation of the pos- 
terior distribution, the ratio of the standard deviation of the distri- 
bution to its mean value, is reported. 
4. Results 
4.1. Simulations 
Table 1 shows the mean (standard deviation) NMSE between 
the estimated and true kinetic parameters values for both the hi- 
erarchical Bayesian and non-linear least squares implementations, 
with the results of the Mann-Whitney U test . The NMSE is signifi- 
cantly lower for the Bayesian method compared to the non-linear 
least squares. The NMSE is also significantly lower for the non- 
linear least squares with 100 initialisations as compared to one ini- 
tialisation ( p < 0.0 0 01). Example parameter maps from both meth- 
ods are compared to the true parameter maps in Fig. 3 . A signif- 
icantly higher NMSE was found in the stress simulations with a 
perfusion defect using the non-hierarchical approach (0.24 (0.15), 
p < 0.001). A comparison of the computed MBF parameter maps 
for an example noise realisation shown in Fig. 4 . 
4.2. Patient data 
The median computed MBF value (25th percentile, 75th per- 
centile) was 2.35 (1.9, 2.68) mL/min/mL under stress conditions 
using the proposed Bayesian inference scheme. The equivalent re- 
sults were 2.37 (1.12, 3.01) mL/min/mL using the non-linear least 
squares fitting. However, with the least squares fitting approach 
there is a number of voxels for which the fitting fails completely, 
which are represented as holes in the parameter maps, as seen in 
Fig. 5 . The proposed Bayesian inference technique has zero vox- 
els with estimates converging to upper or lower bounds or outside 
Fig. 3. The ground-truth F b parameter values (left) are compared to values that are estimated using non-linear least-squares fitting with one initialisation (middle left), 100 
initialisations (middle right), and the proposed Bayesian inference method (right) for two random noise realisations of the simulations mimicking stress-inducible ischaemia 
(top and middle) and one random noise realisation of the rest simulations (bottom). The Bayesian inference is significantly closer to the ground-truth with fewer outliers. 
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Fig. 4. The comparison between the hierarchical and non-hierarchical approach for an example noise realisation with the same ground-truth MBF maps at stress with a 
simulated perfusion defect as shown in Fig. 3 . For the non-hierarchical approach, two different values for F b prior have been applied. This shows the effect of using prior 
distributions with fixed means which influence the information from the data to drive the parameter estimate towards the prior value. 
Fig. 5. A comparison of Bayesian inference versus least-squares fitting with 100 random initialisations for the three acquired slices for a patient with an overt perfusion 
defect (as indicated by the arrows in the first row). While both techniques identify the area of ischaemia the least-squares fittings have severe speckle-like noise and even 
gaps where the fitting has failed. This makes it more difficult to accurately delineate the boundaries of the ischaemic area and can lead to areas where the ischaemia is 
missed. 
physiological ranges. The least-squares fitting fails for an average 
(standard deviation) of 12.9% (12.4%) of voxels per slice. Addition- 
ally, a MBF value of greater than 5 mL/min/mL (considered to be 
outliers) was found in 7.5% of voxels using least-squares fitting but 
never observed with the Bayesian inference. All kinetic parameter 
values are quoted in Table 2 . The median (25th percentile, 75th 
percentile) coefficient of variation of the Bayesian posterior was 
6.6% (3.3%, 11.7%). A maximum value of 87.7% was achieved with 
0.8% of voxels having a parameter with a coefficient of variation 
greater than 50%. 
The assessment of the presence of coronary artery disease 
based purely on the quantitative flow maps obtained using 
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Fig. 6. An example slice where the Bayesian fitting (right) has correctly identified ischaemia but the noisy least squares fitting (middle) makes it difficult to identify the 
ischaemia, particularly in the infero-septal wall. The identified areas of ischaemia are indicated on the original MR image (left). 
Table 2 
Median (25th percentile, 75th percentile) kinetic parameter esti- 
mates, on the patient data, using the Bayesian inference and non- 
linear least squares fitting approaches. 
Parameter Bayesian Non-linear least squares 
F b (mL/min/mL) 2.35 (1.9, 2.68) 2.37 (1.12, 3.01) 
v p (%/100) 0.09 (0.05, 0.13) 0.07 (0.03, 0.13) 
v e (%/100) 0.21 (0.13.0.31) 0.19 (0.12, 0.29) 
PS (mL/min/mL) 0.88 (0.59,1.45) 3.3 (0.61, 4.74) 
Bayesian inference matches the visual assessment in all 24 slices. 
When using the maps obtained by the least-squares fitting, a cor- 
responding assessment is achieved in 16/24 slices. The computed 
flow parameter maps under stress conditions for an example pa- 
tient with a perfusion defect are shown in Fig. 5 . The identified ar- 
eas of ischaemia are indicated with a blue arrow in the original MR 
images. An example of a slice where the least-squares fitting fails 
to correspond to the visual assessment is shown in Fig. 6 . The vi- 
sual assessment concluded that there is reduced uptake of contrast 
agent in both the inferior and infero-septal segments. This clearly 
corresponds with the Bayesian inference. The least-squares fitting 
is extremely noisy and the ischaemic area is under-estimated in 
the inferior segment and almost completely missed in the infero- 
septum. Fig. 7 . shows all four kinetic parameters (left column) with 
the coefficient of variation of the MCMC sample of the parameter 
posterior distribution (right column). 
5. Discussion 
In this work, the use of Bayesian inference to estimate tracer- 
kinetic parameters from myocardial perfusion MRI data is investi- 
gated. This approach incorporates both spatial prior knowledge and 
prior knowledge on the kinetic parameter values. It also enables 
the computation of posterior distributions over the model param- 
eters. It is compared to the more traditional method of parameter 
estimation, non-linear least squares fitting. This comparison first 
assesses the accuracy and reproducibility of the parameter estima- 
tions in a simulated, but realistic, setting. The two methods are 
also compared using patient data to assess the success of disease 
detection using the quantitative flow maps. 
As discussed, a possible alternative approach is to use a 
simpler model for the quantitative modelling such as using 
a Fermi-constrained deconvolution ( Jerosch-Herold et al., 1998 ; 
Zarinabad et al., 2012 ). The model to be fit to the data is simpler 
and has fewer parameters and thus can be fit more reliably, with 
less frequent failed fittings. However, such an approach only allows 
the resolution of MBF and the other parameters have no physio- 
logical interpretation. It is hypothesised that the extra physiolog- 
ical parameters that can be resolved using the two-compartment 
exchange model may allow a more informative assessment of the 
tissue. Tracer-kinetic models can also be fit more reliably on a 
segment-wise level due to the reduced noise after the signal av- 
eraging. However, it has been shown that the reduction of spa- 
tial resolution leads to a loss of diagnostic information ( Villa et al., 
2016 ; Zarinabad et al., 2015 ). It is also likely that increasing the 
number of time points that are sampled may increase the relia- 
bility of the estimates but this may not be possible in a clinical 
setting. 
Lehnert et al. have also recently proposed the use of spatial 
regularisation ( Lehnert et al., 2018 ). In this work, a Tikhonov (L2- 
norm) regularisation term is added to the cost function to be used 
in a gradient-based optimisation process. However, this is known, 
and seen in this work, to introduce smoothing over physiological 
borders where a large difference in kinetic parameters occurs. In 
fact, in Kelm et al. ( 2009 ) it was shown that a L1-norm regularisa- 
tion is more suitable in applications that possess sharp edges be- 
tween kinetic parameters, such as myocardial perfusion MRI. This 
motivates the use of a Laplace prior in our work which is equiv- 
alent to L1-norm regularisation. The benefits of the Bayesian ap- 
proach also include the use of the MCMC exploration of parameter 
space which is less susceptible to local optima than gradient-based 
optimisations. Bayesian inference also yields an approximation of 
the posterior distribution of the parameters rather than a point- 
estimate with no indication of uncertainty. 
Bayesian inference of tracer-kinetic parameters using DCE-MRI 
has been proposed previously ( Dikaios et al., 2017 ; Orton et al., 
2007 ; Schmid et al., 2006 ) and has in general been shown to be 
more reliable than non-linear least squares fitting. This work is 
however the first application to myocardial perfusion data, to our 
knowledge. The main innovation of this work is the utilisation of 
hierarchical priors. As discussed, hierarchical models allow model 
parameters to vary by group. The effect of using fixed priors is 
shown in Fig. 4 . where the parameter estimates cannot adapt to 
areas that are largely different from the prior information (for ex- 
ample a perfusion defect). In this application, this is desirable in 
order to avoid the averaging effects between areas of ischaemia 
and healthy myocardium without having to distinguish between 
the two groups a priori . Hierarchical modelling has been applied 
to DCE-MRI data by Schmid et al. ( 2009 ) in the setting of a clinical 
trial where two scans were acquired per patient, before and after 
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Fig. 7. Parameter maps for the four kinetic parameters of the 2CXM. The coefficient of variation represents the uncertainty about the parameter estimate and could be 
incorporated into the clinical decision making process. Black arrows are used to compare areas of high uncertainty to the respective parameter estimates. 
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treatment, leading to a temporal change in the kinetic parameters 
and thus two distinct groups of patients. This is different to our 
work which instead treats individual voxels in the spatial context 
as being from distinct groups, healthy or diseased. As such, in their 
study it is known a priori whether a scan was pre- or post-therapy, 
unlike in the current study where it is impossible to know whether 
a voxel is diseased. 
Using the simulations, it was shown that the use of multiple 
different initial conditions improves the results of the non-linear 
least squares fitting as it helps the optimisation avoid local optima. 
However, it is still found in this work that the Bayesian inference 
technique presented is significantly more accurate than the stan- 
dard least-squares fitting as evidenced by the NMSE between the 
estimated and true parameter values. Furthermore, the variability 
of the estimates is reduced, as shown by the lower standard de- 
viation and the estimates are more reproducible across different 
noise realisations. The benefit of using a hierarchical model is also 
demonstrated. It is seen that in the presence of areas of reduced 
MBF, the prior knowledge of stress MBF values does not apply and 
the non-hierarchical model cannot account for the differences in 
groups of voxels (ischaemic and healthy). This leads to an averag- 
ing of the information from the data and the prior information and 
thus an over-estimation of MBF in these areas. 
Naturally, there are no ground-truth values for comparison with 
the patient data estimates. However, the Bayesian parameter esti- 
mation leads to reduced numbers of outliers and failed fittings as 
compared to the least-squares fitting. The effect of this is shown in 
the parameter maps in Fig. 5 . In this example, the perfusion defect 
in the inferior segment of the myocardium is clearly identified us- 
ing both the Bayesian inference and least-squares fitting. However, 
there is still some speckle-like noise present in the least-squares 
estimates, even after 100 repeated fittings. The noisy estimates can 
make it difficult to delineate the boundaries of the ischaemia and 
in this case lead to the underestimation of the extent of the is- 
chaemia. It is clear from that the Bayesian inference is identifying 
correctly the area of reduced contrast uptake in the inferior seg- 
ment, which is visible in the original MR image at the correct win- 
dowing level and is easily picked up when assessing the quantita- 
tive flow maps. 
Recent work, as presented by Kellman et al. ( 2017 ) has shown 
reproducible global MBF values, using similar tracer-kinetic mod- 
els, in a consistent population of healthy volunteers ( Brown et al., 
2018 ) and a good correlation with the MBF values derived from 
positron emission tomography (PET) ( Engblom et al., 2017 ) using 
a least-squares fitting approach. However, this work still shows 
a high within-subject variance between repeated studies. Further- 
more, as shown in this study there is a high level of coupling be- 
tween the model parameters and thus it is not possible to judge 
the reliability of the model fitting by evaluating a single parame- 
ter. 
The unreliability of the tracer-kinetic parameter estimates has 
also been widely reported in the literature, Broadbent et al. ( 2013 ) 
reported failed fittings in 10% of cases on a segment-wise level. 
This is despite the fact they considered curves which have been 
averaged over a segment of the myocardium to boost SNR. Likhite 
et al. ( 2017 ) also showed incorrect model fits in a simulated setting 
as a result of the parameter coupling. Schwab et al. ( 2015 ) reports 
a median flow value (25th percentile, 75th percentile) of 3.055 
(1.197,1168.4) mL/min/mL using the 2CXM model with the conven- 
tional least-squares fitting approach. The 75th percentile value re- 
ported is well in excess of 100 times of the range of values that 
are physiologically feasible. Both the mean and 75th percentile are 
lower in the results we have presented, due to the bounds used 
in the optimiser in our implementation but we also found a num- 
ber of failed fittings and outliers. Furthermore, in this work the PS 
values are extremely variable which could be due to the short ac- 
quisition period. Capillary permeability is known to affect the later 
part of the curves and this process may not be fully observed. This 
indicates the unreliability of conventional perfusion estimates and 
hence the difficulty of the clinical translation of quantitative perfu- 
sion analysis is apparent. 
The difficulty associated with the least-squares fitting is due 
to the ill-posedness of the parameter estimation problem and the 
complex nature of the cost function which can contain many lo- 
cal optima. The gradient-based optimisation schemes are thus sen- 
sitive to noise and susceptible to converging to the local minima 
and thus returning inaccurate parameter estimates ( Dikaios et al., 
2017 ; Kelm et al., 2009 ). This problem is exacerbated by the rela- 
tive complexity of the 2CXM relative to the observed data and the 
complex errors introduced by the imaging process. The result of 
this is the noisy and often inaccurate estimates seen in this study. 
Further well known issues with the standard least-squares fit- 
ting technique are that it is difficult to assess the uncertainty of the 
estimates and that these estimates are strongly dependant on the 
initial conditions of the optimisation process. The latter of these 
issues can be mitigated by using many randomly chosen initial po- 
sitions but there is no structured or robust approach to doing this. 
These issues combine to limit the applicability of quantitative per- 
fusion analysis in a clinical setting. Indeed, the patient data exper- 
iments show that the successful clinical classification of patients 
is worse with the least-squares fitting while perfect results are 
achieved with the Bayesian inference, albeit with a small sample 
size. The Bayesian inference does not depend on the initialisation 
of the optimisation as a burn-in period is used and these sample 
values are discarded. Furthermore, it provides a natural framework 
for quantifying the uncertainty of the estimates through the com- 
putation of the a posteriori probability distribution of the parame- 
ters. 
In this work, using Bayesian inference, a median flow value 
(25th percentile, 75th percentile) of 2.35 (1.9, 2.68) mL/min/mL is 
computed. The 25th and 75th percentile values are well within the 
range of what is physiologically feasible, showing the increased re- 
liability of the parameter estimates obtained using Bayesian infer- 
ence. Despite the fact that these studies have been conducted with 
different cohort of patients it still serves to show the significant 
improvement that is gained by employing a Bayesian inference ap- 
proach to the parameter estimation. 
The coefficient of variation of the posterior distribution is used 
as a measure of uncertainty in the parameter estimate. The re- 
ported values indicate a reasonable level of confidence in the pa- 
rameter estimates with the median coefficient of variation being 
6.6%. However, higher coefficients of variation are also found, in- 
dicating high uncertainty in some regions. In Fig. 7 ., in the MBF 
parameter map ( F b ), it is seen that there is a high level of uncer- 
tainty at the border between the ischaemic and healthy regions 
(indicated by arrows). It makes sense that there more uncertainty 
in these border regions and it could possibly be as a result of con- 
flicting information from its neighbouring voxels which could be 
either ischaemic or healthy. In the PS parameter map, there is also 
an isolated area of reduced permeability. However, it is seen to be 
associated with a high level of uncertainty. This uncertainty can 
be incorporated into an assessment of whether or not there is re- 
duced capillary permeability here. Thus, this uncertainty measure 
may prove to be useful in the clinical decision-making process but 
further work on this topic is warranted. 
6. Limitations 
One of the main criticisms of MCMC algorithms is the large 
computational cost involved in accurately approximating the poste- 
rior distribution, though the use of multiple random initialisations 
in the least-squares fitting is similarly computationally expensive. 
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In this work, the Bayesian takes approximately 30 min per imag- 
ing slice, as opposed to 3 min for the non-linear least squares fit- 
ting. However, the implementation of the Bayesian approach was 
not optimised and the computational cost could potentially be ad- 
dressed using an efficient GPU-based implementation. 
A limitation of tracer-kinetic modelling, in general, is that the 
models used are simplified versions of the underlying processes. 
The aim of this work was to examine whether Bayesian inference 
can yield more reliable parameter estimates that non-linear least 
squares fitting with the 2CXM. In the current work no effort was 
made to investigate whether this is the most suitable model for 
the application. 
There are no ground-truth parameter values for patient data 
and as such there is no way to comment directly on the accu- 
racy of the parameter estimates. The absolute quantitative accuracy 
needs validation in comparison to a gold standard technique such 
as microspheres. Further work is also required on the clinical util- 
ity of the findings. In this work, diagnostic accuracy is only com- 
pared with the expert clinical assessment, however future work 
will involve comparisons with the gold standard examinations, in- 
vasive coronary angiography and fractional flow reserve, in a larger 
patient cohort. 
7. Conclusion 
Tracer-kinetic parameters can be accurately and robustly in- 
ferred from myocardial perfusion MRI using hierarchical Bayesian 
inference. The use of a MCMC fitting scheme and the inclusion of 
spatial prior knowledge improves the reliability of the parameter 
estimation as compared with least-squares fitting. As a result of 
the improved model fitting, the diagnostic capabilities of the tech- 
nique is increased. 
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Appendix 
A.1. Residue function 
The pair of coupled differential Eqs. (1) and (2) can be solved 
analytically using the Laplace transform to yield a solution in the 
form: 
C ( t ) = R F ( t , ) ∗C AIF ( t − τ0 ) 
The residue function R F is given as: R F ( t , ) = A exp ( αt ) + 
( 1 − A ) exp( βt), where: 
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6.3 Correction
In the appendix of Section 6.2, it is stated that:
RF(t,θ) = Aexp(αt)+(1−A)exp(β t). (6.8)
This should read as:




As discussed, stress perfusion CMR is now an established technique for the assessment of
patients with CAD [2, 3] and it is playing an expanding role in the assessment of patients with
angina and coronary microvascular dysfunction (MVD) [106]. Although a high diagnostic accu-
racy and prognostic value is found with visual assessment at experienced centres, quantification
is required to make this a widespread clinical reality. Therefore, this chapter presents a prelimi-
nary, proof of principle evaluation of the automated pipeline for stress perfusion quantification
that was presented in Chapters 4, 5, and 6. In particular, the ability of stress perfusion CMR to
detect myocardial ischaemia is demonstrated, both in patients with obstructive epicardial CAD
and MVD. This paves the way for a more thorough validation study and the subsequent clinical
adoption of quantitative stress perfusion CMR.
7.2 Material and methods
7.2.1 Patients
In total, 47 patients were included in this study. Of these, 36 patients with known or suspected
CAD referred on clinical grounds for a stress perfusion CMR, who had a subsequent invasive
coronary angiography, were retrospectively included. A further 11 patients who had MVD
diagnosed by exclusion, demonstrable ischaemia with angiographically smooth coronary
arteries, were also included. All patients had invasive coronary angiography within 3 months
and the cut-off point for coronary lumen stenosis was 70% for epicardial vessels. All invasive
angiographic images have been reviewed by consensus of expert operators.
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7.2.2 Image acquisition
All examinations were performed on a 3T system (Achieva TX, Philips Healthcare, Best,
The Netherlands) using a 32-channel cardiac phased array receiver coil. Perfusion images
were acquired in 3 LV short-axis slices (apical, mid-cavity, and basal) at mid-expiration with
a saturation-recovery gradient echo method (repetition time 3.0 ms, echo time 1.0 ms, flip
angle 15°, saturation-recovery delay 120 ms, sensitivity encoding (SENSE) parallel imag-
ing, representative spatial resolution 1.5x1.5x10 mm3). Stress images were acquired during
adenosine-induced hyperaemia (140µg/kg/min). 0.075 mmol/kg of bodyweight gadolinium
(Gd) extracellular contrast agent (gadobutrol, Gadovist, Bayer, Germany) was injected at 4
mL/s followed by a 20-mL saline flush for each perfusion acquisition. Each bolus of gadobutrol
was preceded by a diluted pre-bolus with 10% of the dose to allow quantification of perfusion,
according to published methods [48].
7.2.3 Image processing
The perfusion images were corrected for respiratory motion (Chapter 4) and processed fully-
automatically using our deep learning-based processing pipeline (Chapter 5). Pixel-wise time
signal intensity curves were extracted from the myocardial mask and signal intensity curves
were subsequently split into the time intervals corresponding to the pre bolus injection and the
main bolus injection for quantification, using Bayesian inference (Chapter 6). The pixel-wise
MBF estimates were assigned to standard AHA segments using the automatically computed
RV insertion points. AHA segments are attributed to coronary perfusion territories as described
by Cerqueira et al. [107]. Each AHA segment is further sub-divided into an endocardial and
epicardial layer to yield 32 segments. For the purpose of detecting CAD, Lockie et al. [79]
validated the use of the mean value of the two lowest MBF values in a perfusion territory to
represent that vessel. This work uses the mean of the four lowest MBF values as our segments
are half the size.
7.2.4 Quantitative analysis
A series of comparisons are performed. The first of which is to assess the ability of quantitative
stress CMR to detect ischaemia and thus compares the patients with no significant CAD (CAD-)
against the groups of patients with ischaemia, that is those with significant CAD (CAD+) or
MVD. The second assessment is the ability to distinguish between significant CAD and no
significant CAD and compares the CAD+ and CAD-. This is done on both a per-patient and
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n = 47
Age (years) 59.66 ± 8.03
Male 26 (55)






Previous PCI 12 (26)
Previous CABG 0 (0)
Values are n (%) or mean ± SD
Table 7.1 Baseline demographics of the patient cohort. PCI, percutaneous coronary intervention;
CABG, coronary artery bypass grafting.
per-coronary vessel level. The final assessment is the ability to detect MVD in the setting of
patients with anatomically smooth coronary arteries and thus compares CAD- against MVD.
7.2.5 Statistical analysis
The data are presented as mean ± standard deviation (SD) and compared using two-sided
Student t-tests. p values < 0.05 were considered statistically significant. ROC curve analysis
was used to report the diagnostic accuracy of the proposed approach. The data was analysed on
both the per-patient and per-coronary vessel level. All statistical analysis was performed using
SciPy and Pingouin [108, 109].
7.3 Results
The baseline patient characteristics are summarised in Table 7.1. 17 patients had no significant
coronary lesions or MVD. In 19 patients with CAD, there was 38 vessels with significant
lesions and 11 patients had MVD. The findings of the angiography data are shown in Table 7.2.
45/47 patients were successfully analysed with two having failed contrast injections. The
mean MBF value over all patients was 1.93± 0.52 ml/min/g. The other microcirculatory
parameters estimated were vb = 0.08±0.04, ve = 0.18±0.08, and PS= 0.65±0.31 ml/min/g.
The distribution of global MBF values for the three patient groups (CAD+, MVD, and CAD-)
is shown in Figure 7.1. The mean MBF in CAD- patients was 2.35±0.46 ml/min/g, in MVD
patients was 1.72± 0.3 ml/min/g, and in CAD+ patients was 1.67± 0.36 ml/min/g. The
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n = 47
No significant CAD 17 (36)
1-vessel disease 7 (15)
2-vessel disease 2 (4)
3-vessel disease 10 (21)
MVD 11 (23)
Values are n (%)
Table 7.2 Angiographic findings
MBF was significantly reduced in both the CAD+ and MVD groups as compared to the CAD-
group (both p < 0.01), indicating the presence of significant ischaemia. There was no statistical
difference in the mean MBF between the MVD and CAD+ patients (p = 0.53).
Fig. 7.1 The distributions of global MBF values in the different patient groups.
In the setting of patients with known or suspected CAD, the ROC curve in Figure 7.2
shows that quantitative stress perfusion CMR distinguishes well between CAD- and CAD+
patients. The area under the curve (AUC) of the ROC curve was 0.94 and using an threshold of
1.34 ml/min/g to detect CAD achieved a sensitivity of 94.4%, a specificity of 93.8%, and a
diagnostic accuracy of 91%. Figures 7.3 and 7.4 show examples of quantitative perfusion maps
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Fig. 7.2 The ROC analysis for the diagnosis of CAD on a per-patient level.
and the corresponding segmental analysis for patients correctly classified as CAD- and CAD+,
respectively.
Fig. 7.3 Quantitative MBF maps and 32 segment representation for a CAD- patient.
This diagnostic power is reduced on the per-vessel assessment. The ROC curve is shown
in Figure 7.5 and the AUC of the ROC curve is 0.86, with the threshold of 1.31 ml/min/g
giving a sensitivity of 87.3%, a specificity of 77.1%, and a diagnostic accuracy of 83.3%. The
mean MBF in regions supplied by vessels with a stenosis was 1.19±0.28 ml/min/g. This was
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Fig. 7.4 Quantitative MBF maps and 32 segment representation for a CAD+ patient.
Fig. 7.5 The ROC analysis for the diagnosis of CAD on a per-vessel level.
significantly higher in regions supplied by vessels without a stenosis at 1.8±0.59 ml/min/g
(p < 0.01). An example patient with misclassified vessels is shown in Figure 7.7. This patient
has triple vessel disease but is classified as being ischaemic in only the LAD territory. The
ischaemia in the circumflex region is subtle and restricted to sub-endocardial region in the
mid slice which is not picked up by the segmental analysis. Furthermore, the ischaemia in the
RCA territory is visible in the septal/inferoseptal segments of the mid and apical slices but the
perfusion values are in an intermediate range and do not fall below the threshold for ischaemia.
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Fig. 7.6 The distribution of MBF values recorded for each vessel in the CAD+ patients, divided
between positive (for CAD) and negative.
Fig. 7.7 An example of a misclassified patient. The patient has triple vessel disease and while
they are correctly identified as CAD+ by the MBF values, they are misclassified as having
single vessel disease (LAD). There are significant lesions but not significant ischaemia in the
LCx and RCA.
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Fig. 7.8 The ROC analysis for the detection of ischaemia on a per-patient level.
With the inclusion of patients with MVD, the ability of quantitative stress perfusion CMR
to detect patients with myocardial ischaemia is good, as demonstrated by the ROC curve in
Figure 7.8. The AUC of the ROC analysis was 0.91. The optimal threshold for detecting
ischaemia was 1.34 ml/min/g. This threshold gave a sensitivity of 94.4%, a specificity of
85.2% and an overall diagnostic accuracy of 86.7%.
If only the patients with anatomically smooth coronary vessels are included, it gives a
realistic clinical setting to test if quantitative stress CMR can distinguish between CAD- and
MVD patients. The ROC analysis for this situation is shown in Figure 7.9. The AUC is 0.91,
sensitivity is 100% and specificity of 71.7% so that the overall diagnostic accuracy is 85.7%. In
the patients with MVD, the typical diffuse, sub-endocardial ischaemia is seen, particularly in
the (systolic) mid-slice [110]. Examples of these patients are shown in Figures 7.10 and 7.11.
7.4 Discussion
This is a small proof of principle study to establish the feasibility of fully-automatic quantitative
stress perfusion CMR using the methods presented in Chapters 4, 5, and 6. That is, it has
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Fig. 7.9 The ROC analysis for the detection of MVD on a per-patient level.
Fig. 7.10 Quantitative MBF maps and 32 segment representation for a MVD patient.
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Fig. 7.11 Quantitative MBF maps and 32 segment representation for a MVD patient.
been shown that a stress perfusion CMR image series can be automatically processed, motion
compensated, segmented, and tracer-kinetic models can be fit to automatically infer myocardial
blood flow which has a high level of diagnostic accuracy for detecting CAD and MVD. It
removes the subjectivity and laborious processing of the analysis. If these results are found to
generalise well to larger and independent patient groups, this will really make the case for the
widespread clinical adoption of stress perfusion CMR.
The diagnostic accuracy and even the cut-off threshold values found are very similar to
recent, concurrently run, studies [82, 111]. The main advantage of this study is that it was the
first to be truly automatic, including myocardial segmentation and disease classification.
There are, however, limitations to this work. Most notable are the small sample size and
the comparison of the functional perfusion test to an anatomical reference standard. It is well
discussed that the anatomical measurements do not always correlate well to their functional
significance. Therefore, a follow-up study is warranted in which quantitative stress CMR is
compared to appropriate reference standards: fractional and coronary flow reserve.
There is also further future work required. This study was conducted with dual-bolus
acquisitions, methods for dual-sequence acquisitions are now becoming available and should
ease the workflow of future studies [58] but the different acquisition may need different cut-off
thresholds. The diagnostic accuracy could also benefit from future developments. While the
per-patient diagnostic accuracy is very high, this drops significantly when assessing which
vessels are diseased. A physiological cause of this may be some microvascular dysfunction
causing ischaemia in the remote territories of patients with CAD leading to false positives.
It is also likely a consequence of the limitations of the segmental analysis. Small areas of
ischaemia may be averaged out making a segment to be a false negative. False positives are
also possible when the area of ischaemia extends into the neighbouring territory. Two examples
of patients with these characteristics are shown in Figure 7.12. The patient on the left has a
single RCA lesion and the patient on the right has LCx and LAD lesions. Despite the patient on
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the left having disease in fewer vessels, they have more ischaemia and the amount of disease is
over-estimated as the ischaemia extends into the LCx territory. On the right, the disease is not
picked up as the ischaemic burden is not high enough. However, the diagnosis would be clear
to a visual reader based on this quantitative maps and the use of machine learning classifiers to
mimic this may lead to more refined diagnoses. The ability detect CAD from CAD- patients
and MVD from CAD- is shown but the ultimate aim would be to be able to distinguish the
three groups from each other and this may benefit from a similar machine learning classifier.
Fig. 7.12 Example MBF maps from two patients. The patient on the left has extensive ischaemia
arising from disease in one vessel. The patient on the left has two vessel disease but much less




This thesis has dealt with the challenging problem of myocardial perfusion quantification from
stress perfusion CMR images. Myocardial perfusion CMR is a powerful diagnostic tool for
coronary artery disease and has the potential to play a big role in the management of patients
with microvascular dysfunction. It has been, so far, limited by the difficulty of interpreting the
images (as well as factors such as the lack of availability, and the problem of reimbursement in
the United States). Quantitative stress perfusion CMR is potentially the solution to this as it is
not subjective and thus requires less expertise.
This idea is not new and perfusion quantification has been an active research topic for many
years [112]. A major drawback of all these early solutions, however, was that they required
a lot of manual processing, such as segmenting the AIF, segmenting the myocardium, and
motion compensation. Biglands et al. [81] reported that it took roughly one hour per patient
to manually correct the myocardial contours for motion. This level of manual interaction is
clearly not feasible on a routine basis in the clinic. Furthermore, the reliability of the analysis,
particularly the model fitting [6, 55], has been often questioned. This motivated the aim of this
thesis, which was to make the analysis fast, automatic, and more reliable. This work has led to
a solution for quantitative stress perfusion CMR that is robust and truly automated.
Chapter 4 presented an approach for the compensation of respiratory motion which often
precludes accurate quantification. Motion compensation is particularly challenging in DCE-
MRI as it uses saturation recovery sequences and injections of contrast boluses. The contrast
bolus passes rapidly through the region of interest leaving a series of time dynamics with
very different levels and regions of contrast enhancement. As traditional image registration
approaches assume there is a constant mapping between anatomical regions and signal intensity
values, this assumption is invalidated by the passing contrast. Outside of where and when
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the contrast is passing, the signal is saturated. With little signal to work with, intensity-based
registrations are sensitive to noise and subject to failing.
The data decomposition technique robust PCA is shown to be able to separate the dynamic
contrast-enhancement from the baseline anatomical signal. The rigid motion can then be
estimated in the absence of the dynamic contrast-enhancement and subsequently applied to
the original image series. The remaining motion appears to be noise-like and can be removed
using a PCA-decomposition and the image series can again be registered to the de-noised
motionless synthetic image series to remove any remaining motion. It is well documented
that the validation of image registrations is challenging [113], in this work the quantitative
evaluation is based on assumptions about motionless image series. It is shown that the time-
intensity curves evolve more smoothly and that the rest perfusion maps show more spatial
homogeneity after motion compensation. Perhaps more telling is that expert readers visually
scored the quality of the motion compensation higher than the state-of-the-art approach.
In Chapter 5, the first deep learning-based pipeline for stress perfusion CMR was described.
This leverages the huge advances made in computer vision and image processing, based on
convolutional neural networks, to give a previously unseen level of automation to the processing.
The pipeline seeks to mimic how a manual operator would have processed the data in the past.
A first CNN picks the time dynamic with maximum contrast and this image is then fed to a
further network which computes a bounding box around the LV and myocardium. Motion
compensation is then performed within this bounding box. The resulting image series is finally
segmented and the RV insertion point is detected. The training labels were produced by expert
operators with a vast amount of experience in perfusion quantification. The algorithms were
validated against labels from the same operators on the held-out test set. The automated deep
learning approach was shown to closely match the expert labels at all stages. Most importantly,
there was also a good agreement between the derived MBF values from both the automated
and manual systems.
Chapter 6 aimed to improve the reliability of the kinetic parameters being inferred. This
was done by enforcing well-known and physiological prior information. In particular, the
knowledge that neighbouring pixels are likely to have similar kinetics was exploited. This prior
information can be naturally included in a Bayesian inference framework and was combined
with probabilistic constraints to ensure the estimated parameters were within physiological
ranges. Since ground-truth kinetic values are not available in vivo, this was first validated in
a series of simulated studies and shown to outperform the traditional non-linear least squares
fitting estimates. Visually, the parameters estimated with Bayesian inference in patients
outperformed the least-squares parameters and in a small cohort they were shown to match the
clinical assessment of the patients.
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The main validation for the combined approaches from Chapters 4, 5, and 6 comes in
Chapter 7. Here it is shown, in a cohort of 47 patients that the automatically derived quantitative
MBF values can diagnose CAD and in the setting of patient with smooth coronary arteries, it
can diagnose coronary MVD. As discussed, this study is somewhat limited and a follow-up
study in a larger cohort versus a functional marker, such as FFR, is warranted.
8.2 Context
Stress perfusion CMR has undoubted high diagnostic accuracy [2] and has outperformed SPECT
in randomised trials [3]. It has been shown to have high prognostic value and be cost-effective
[29]. Perhaps most importantly, the results of MR-INFORM [4] showed that it is non-inferior
to invasive FFR measurements for the management of patients [4]. Additional advantages over
the alternative nuclear perfusion imaging techniques are the higher spatial resolution and lack
of ionising radiation. Thus, it should play a significant role in the management of patients with
suspected CAD. The use of stress perfusion CMR should only benefit from the analysis being
made easier and less subjective.
This works comes at an important time. Through-out the last 20 years there has been a
trend away from anatomical imaging towards functional assessments of CAD. This trend made
sense based on the intuition that there must be demonstrable ischaemia for a patient to benefit
from being revascularised. It also seemed to be backed up by the FAME I and FAME II trials
which showed better outcomes for patients guided by functional or ischaemia tests [114, 115].
However, recently, anatomical imaging has undergone a resurgence based on the results of
the PROMISE trial [116] (and followed-up by the SCOT-HEART trial [117]) which showed
that patients can be equally well managed by anatomical CCTA imaging. This resurgence has
been accelerated by the (mis-)interpretation of the results of the ISCHEMIA trial [118]. Despite
the fact that the trial was designed to compare invasive interventions versus optimal medical
therapy and not to compare imaging tests, it was reported that there was no correlation between
ischaemia and benefit from revascularisation. It is important to observe that the ISCHEMIA
used local reads for the stress tests. As discussed extensively in this thesis, the diagnostic
accuracy of stress imaging tests falls dramatically outside of highly experienced centres and
this is likely to have impacted the results. This is clearly an area where emerging technology,
such as quantitative perfusion CMR, has the potential to add real value. Furthermore, the use
of CCTA in ISCHEMIA to exclude left main disease has led to it being marketed as the first
in line imaging test for CAD. This is all in spite of CCTA only being able to reliably rule out
CAD and not having a positive predictive value, as it does not infer the presence of ischaemia.
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Finally, a further major advantage of ischaemia testing over anatomical imaging is in
patients that present with anatomically smooth coronary arteries and angina, from microvascular
dysfunction. MVD causes ischaemia [106] and as was shown in this thesis, there is a role for
ischaemia imaging in these patients. The quantitative analysis may finally allow these patients
to be managed on the basis of a non-invasive test.
8.3 Future work
The methods presented in this thesis represent a significant improvement on methods previously
used in the field. The robust motion compensation alleviates one of the significant challenges
and automated processing makes it more accessible. This is the first deep learning system for
stress perfusion CMR, though more are now becoming available [119]. However, there are still
opportunities for future work in the field. As discussed, the output of the quantification would
be a suitable input for a further machine learning classifier for disease classification and staging.
This would circumnavigate the discussed limitations of the AHA segment model. A limitation
of the proposed methods is the processing time taken for the analysis, the image registration
and Bayesian inference are computationally intensive. These steps could be replaced with deep
learning systems [120] which are quicker to deploy on new data.
The power of deep learning could be utilised in a range of other tasks from which the
analysis would benefit. This includes the image reconstruction, to allow images to be acquired
faster, and super resolution algorithms to increase both the in-plane spatial resolution and the
LV coverage. There has also been a recent interest in developing quality control measures for
automated processing systems [121, 122]. The system presented in this thesis is not infallible
and would benefit from an assessment of image quality prior to processing and a method to
detect failed cases.
In conclusion, while this work has laid the foundations of fully automatic quantitative stress
perfusion CMR, much more work can be done to make the analysis more accurate, reliable, and
fast. This further work will likely leverage the tremendous improvements in image processing
made possible by advances in machine learning. The results presented, and in the literature,
are promising, but in the end trials will be needed to validate it, preferably including less
specialised centres.
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